# EDGAR Filing Document

**Accession Number:** 0001902649
**File Stem:** 0001140361-26-020390
**Filing Date:** 2026-5
**Character Count:** 128528
**Document Hash:** 233a5ac4956b55da2168caff19a516fc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-26-020390.hdr.sgml**: 20260511

**ACCESSION NUMBER**: 0001140361-26-020390

**CONFORMED SUBMISSION TYPE**: SC TO-I

**PUBLIC DOCUMENT COUNT**: 17

**FILED AS OF DATE**: 20260511

**DATE AS OF CHANGE**: 20260511

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BlackRock Private Credit Fund
- **CENTRAL INDEX KEY:** 0001902649

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94050
- **FILM NUMBER:** 26961105

**BUSINESS ADDRESS:**
- **STREET 1:** 50 HUDSON YARDS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001
- **BUSINESS PHONE:** (212) 813-5800

**MAIL ADDRESS:**
- **STREET 1:** 50 HUDSON YARDS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BlackRock Private Credit Fund
- **CENTRAL INDEX KEY:** 0001902649

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I

**BUSINESS ADDRESS:**
- **STREET 1:** 50 HUDSON YARDS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001
- **BUSINESS PHONE:** (212) 813-5800

**MAIL ADDRESS:**
- **STREET 1:** 50 HUDSON YARDS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001

### UNITED STATES <br>

### SECURITIES AND EXCHANGE COMMISSION <br>

#### WASHINGTON, D.C. 20549

### SCHEDULE TO <br>

#### (Rule 13e-4)

#### TENDER OFFER STATEMENT PURSUANT TO SECTION 14(D)(1) OR 13(E)(1) <br>

#### OF THE SECURITIES EXCHANGE ACT OF 1934

### BlackRock Private Credit Fund <br>

#### (Name of Issuer)

#### BlackRock Private Credit Fund <br>

#### (Name of Person(s) Filing Statement)

#### Class S, Class D and Institutional Shares of Beneficial Interest <br>

#### (Title of Class of Securities)

#### BRY4333P7, BRY42WTV3 and BRY13VCK2 <br>

#### (CUSIP Number of class of securities)

#### John M. Perlowski <br>

#### BlackRock Capital Investment Advisors, LLC <br>

#### 50 Hudson Yards <br>

#### New York, NY 10001 <br>
(212) 810-5300

#### (Name, Address and Telephone No. of Person Authorized to Receive Notices and Communications on Behalf of the Person(s)

#### Filing Statement)

#### With copies to:

---

| | |
|:---|:---|
| **Steven Grigoriou, Esq.** <br>**Simpson Thacher & Bartlett LLP** <br>**900 G Street, NW**<br>**Washington, DC 20001** | **Jonathan Gaines, Esq.** <br>**Simpson Thacher & Bartlett LLP** <br>**425 Lexington Avenue**<br>**New York, NY 10017** |

---

#### May 11, 2026 <br>

#### (Date Tender Offer First Published, Sent or Given to Security Holders)

---

| | | |
|:---|:---|:---|
| ☐ | Check the box if the filing relates solely to preliminary communications made before commencement of a tender offer.  | Check the box if the filing relates solely to preliminary communications made before commencement of a tender offer.  |
| Check the appropriate boxes below to designate any transactions to which the statement relates:  | Check the appropriate boxes below to designate any transactions to which the statement relates:  | Check the appropriate boxes below to designate any transactions to which the statement relates:  |
|  | ☐  | third-party tender offer subject to Rule 14d-1.  |
|  | ☒  | issuer tender offer subject to Rule 13e-4.  |
|  | ☐  | going-private transaction subject to Rule 13e-3.  |
|  | ☐  | amendment to Schedule 13D under Rule 13d-2.  |
| Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐ | Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐ | Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐ |

---

------

---

| | |
|:---|:---|
| **Item 1.**<br>| **Summary Term Sheet.**  |

---

Reference is made to the Summary Term Sheet of the Offer to Purchase (as defined below) that is attached hereto as Exhibit (a)(1)(ii) and is hereby incorporated by reference.

---

| | |
|:---|:---|
| **Item 2.**<br>| **Subject Company Information.**  |

---

(a) The name of the issuer is BlackRock Private Credit Fund (the "Fund"). The Fund is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the "1940 Act"). It is organized as a Delaware statutory trust. The principal executive office of the Fund is located at 50 Hudson Yards, New York, NY 10001 and the telephone number is (212) 810-5800. 

(b) The title of the securities that are the subject of the offer to purchase and the related Letter of Transmittal ("Offer to Purchase" and the tender offer made thereby, the "Offer") are Class S common shares of beneficial interest (the "Class S Shares"), Class D common shares of beneficial interest (the "Class D Shares") and Institutional common shares of beneficial interest (the "Institutional Shares" and together with Class S Shares and Class D Shares, the "Shares") or portions thereof. As of the close of business on March 31, 2026, there were 70,448,678 Shares outstanding. 

(c)<br> Shares are not traded in any market.

---

| | |
|:---|:---|
| **Item 3.**<br>| **Identity and Background of Filing Person.**  |

---

(a) The Fund is tendering for its own Shares. The information required by this Item is set forth in Item 2(a) above. BlackRock Capital Investment Advisors, LLC (the "Adviser") serves as the investment manager for the Fund. The Adviser is located at 50 Hudson Yards, New York, NY 10001 and its telephone number is (212) 810-5800. The members of the Fund's Board of Trustees (the "Board") are Eric J. Draut, John Perlowski, Andrea Petro, Marueen Usifer, and Philip Tseng (each, a "Trustee"). The Chief Executive Officer is Philip Tseng, the President is Jason Mehring, the Chief Financial Officer and Treasurer is Erik L. Cuellar, the Chief Operating Officer is Patrick Wolfe, the Chief Compliance Officer is Charles Park and the General Counsel and Secretary is Diana Huffman. Philip Tseng and Dan Worrell are the Co-Chief Investment Officers of the Fund. The Trustees and the executive officers of the Fund may be reached at the Fund's business address and phone number set forth in Item 2(a) above. 

(b)-(c)<br> Not applicable.

---

| | |
|:---|:---|
| **Item 4.**<br>| **Terms of the Transaction.**  |

---

(a)(1)(i)<br> Subject to the conditions set forth in the Offer to Purchase, the Fund will purchase up to 3,522,434 Shares that are tendered by holders of the Fund's Shares ("Shareholders") by 11:59 p.m., Eastern Time, on June 8, 2026 and not withdrawn as described in Item 4(a)(1)(vi).

(ii) The purchase price of a Share (or portion thereof) tendered will be its net asset value as of June 30, 2026 or a later date determined by the Fund if the Offer is extended (in each case, the "Valuation Date"), upon the terms and subject to the conditions set forth in the Offer to Purchase. Reference is made to the Cover Page, Section 2 "Offer to Purchase and Price" and Section 6 "Purchases and Payment" of the Offer to Purchase, which are incorporated herein by reference. 

Each Shareholder that tenders Shares that are accepted for purchase will be sent a letter (the "Acceptance Letter") notifying the Shareholder that the Fund has received and accepted their tender. Such Shareholder will be issued a non-interest bearing, non-transferable promissory note (the "Repurchase Instrument") entitling the tendering Shareholder to receive an amount equal to the value of the Shares accepted for repurchase by the Fund determined as of the Valuation Date. The Repurchase Instrument will be held for the tendering Shareholder by State Street Bank and Trust Company, the Fund's transfer agent (the "Transfer Agent"). Forms of the Acceptance Letter and the Repurchase Instrument are attached hereto as Exhibits (a)(1)(iv) and (a)(1)(v), respectively, and incorporated herein by reference.

(iii)<br> The Offer is scheduled to expire on June 8, 2026 unless extended. Reference is made to the Cover Page, Summary Term Sheet, Section 2 "Offer to Purchase and Price" and Section 5 "Withdrawal Rights" of the Offer to Purchase, which are incorporated herein by reference.

1<br>

------

(iv)<br> Not applicable.

(v)<br> Reference is made to the Cover Page, Summary Term Sheet and Section 7 "Certain Conditions of the Offer" of the Offer to Purchase, which are incorporated herein by reference.

(vi)<br> Reference is made to Section 5 "Withdrawal Rights" of the Offer to Purchase, which is incorporated herein by reference.

(vii) Reference is made to the Cover Page, Section 4 "Procedure for Tenders" and Section 5 "Withdrawal Rights" of the Offer to Purchase, which are incorporated herein by reference. Note that certain Shareholders may be required to deliver their Letter of Transmittal to their Financial Advisor (instead of directly to the Transfer Agent). All Shareholders tendering Shares should carefully review their Letter of Transmittal and follow the delivery instructions therein. 

(viii)<br> Reference is made to Section 4 "Procedure for Tenders" and Section 6 "Purchases and Payment" of the Offer to Purchase, which are incorporated herein by reference.

(ix) Reference is made to the Cover Page, Section 3 "Amount of Tender," and Section 6 "Purchases and Payment" of the Offer to Purchase, which are incorporated herein by reference. 

(x)<br> Reference is made to Section 2 "Offer to Purchase and Price," which is incorporated herein by reference.

(xi)<br> Not applicable.

(xii)<br> Reference is made to Section 10 "Certain U.S. Federal Income Tax Consequences" of the Offer to Purchase, which is incorporated herein by reference.

(a)(2)<br> Not applicable.

(b)<br> Any Shares to be purchased from any officer, Trustee or affiliate of the Fund will be on the same terms and conditions as any other purchase of Shares. To the Fund's knowledge, none of the officers, Trustees, or affiliates of the Fund intends to tender Shares in the Offer.

---

| | |
|:---|:---|
| **Item 5.**<br>| **Past Contracts, Transactions, Negotiations and Agreements With Respect to the Issuer's Securities.**  |

---

(a) The Fund's Prospectus dated April 24, 2026, as supplemented and/or amended from time to time (the "Prospectus"), provides that the Board has the discretion to determine whether the Fund will purchase Shares from Shareholders from time to time pursuant to written tenders. The Adviser expects that it will recommend to the Board that the Fund purchase Shares from Shareholders quarterly. However, the Fund is not required to conduct tender offers. The Fund does not know of any other contract, agreement, arrangement, or understanding, whether contingent or otherwise or whether or not legally enforceable, between the (i) Fund, any of the Fund's executive officers or Trustees, any person controlling the Fund, or any executive officer or director of any corporation ultimately in control of the Fund and (ii) any other person with respect to any securities of the Fund (including any contract, agreement, arrangement, or understanding concerning the transfer or the voting of any such securities, joint ventures, loan or option arrangements, puts or calls, guarantees of loans, guarantees against loss, or the giving or withholding of proxies, consents or authorizations). 

---

| | |
|:---|:---|
| **Item 6.**<br>| **Purposes Of This Tender Offer And Plans Or Proposals.**  |

---

(a)-(b)<br> Reference is made to Section 1 "Background and Purpose of the Offer" of the Offer to Purchase, which is incorporated herein by reference.

(c)<br> Reference is made to Section 8 "Certain Information About the Fund" of the Offer to Purchase, which is incorporated herein by reference. Because Shares are not traded in any market, subsections (6), (7), and (8) of Regulation M-A Item 1006(c) are not applicable to the Fund.

---

| | |
|:---|:---|
| **Item 7.**<br>| **Source and Amount of Funds or Other Consideration.**  |

---

(a)-(b)<br> Reference is made to Section 6 "Purchases and Payment" of the Offer to Purchase, which is incorporated herein by reference.

(c)<br> Not applicable.

2<br>

------

(d) None of the Fund, the Adviser or the Board or any person controlling the Fund, the Adviser or the Board has determined at this time to borrow funds to purchase Shares tendered in connection with the Offer. Depending on the dollar amount of Shares tendered and prevailing general economic and market conditions, the Fund, in its sole discretion, may decide to seek to borrow money to fund all or a portion of the purchase amount for Shares, subject to compliance with applicable law. The Fund expects that the repayment of any amounts borrowed will be financed from additional funds contributed to the Fund by existing or new Shareholders. 

---

| | |
|:---|:---|
| **Item 8.**<br>| **Interest in Securities of the Issuer.**  |

---

(a)<br> Based on the number of Shares outstanding as of March 31, 2026, the following persons own the number of Shares indicated in the below table.

---

| | | |
|:---|:---|:---|
| **Person** | **Shares** | **Percentage of the** <br>**Fund's Outstanding** <br>**Shares**  |
| BlackRock Financial Management, Inc. | 5998843 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.515%  |
| &nbsp;&nbsp;Eric J. Draut | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1077 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.002%  |
| John Perlowski | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| Andrea Petro | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| Maureen Usifer | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| Philip Tseng | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1009 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.001%  |
| Charles C. S. Park | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| Jason Mehring | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;682 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.001%  |
| Erik L. Cuellar | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| Patrick Wolfe | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| Dan Worrell | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4036 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.006%  |
| Diana Huffman | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0% |

---

None of the persons listed above intends to tender any of his or her Shares in the Offer.

Addresses for each of the persons listed above are provided in Item 3.

(b)<br> Reference is made to Section 8 "Certain Information About the Fund" of the Offer to Purchase, which is incorporated herein by reference.

During the past sixty (60) days, the Fund issued an aggregate of approximately 3,353,915 Shares, including Shares issued pursuant to the DRIP, for net proceeds of approximately $78,916,138.16.

In connection with the completion of the Fund's tender offer that commenced on January 30, 2026, the Fund repurchased on or about February 27, 2026, 2,957,174 of its outstanding shares of beneficial interest (including Class I common shares of beneficial interest, Class S common shares of beneficial interest, and Class D common shares of beneficial interest), at a purchase price of $23.52 per share, the net asset value per share as of March 31, 2026, pursuant to the terms of such tender offer, as set forth in the Schedule TO-I filed by the Fund with the SEC on January 30, 2026. The payment of the purchase price of the Shares tendered was made in the form of non-interest bearing, non-transferable promissory notes issued to the Shareholders whose tenders were accepted for purchase by the Fund in accordance with the terms of the Offer. The promissory notes were held by the Fund's transfer agent on behalf of each tendering shareholder. Pursuant to the promissory notes, on or before April 30, 2026, the Fund paid to the tendering Shareholders a total of $69,530,706.73, an amount equal to the aggregate net asset value of the Shares as of the Valuation Date, less the early repurchase deduction, as applicable.

There have been no other transactions in Shares effected during the past sixty (60) days by the Fund, and the Adviser, BlackRock Financial Management, Inc., or any Trustee or executive officer of the Fund, or any person controlling the Fund or the Adviser.

---

| | |
|:---|:---|
| **Item 9.**<br>| **Persons/Assets Retained, Employed, Compensated or Used.**  |

---

(a)<br> No persons have been employed, retained, or are to be compensated by the Fund to make solicitations or recommendations in connection with the Offer to Purchase.

3<br>

------

---

| | |
|:---|:---|
| **Item 10.**<br>| **Financial Statements.**  |

---

(a) The audited financial statements of the Fund for the period ended December 31, 2025, as filed with the SEC on EDGAR on Form 10-K on March 2, 2026, are incorporated by reference. The Fund will prepare and transmit to Shareholders the audited financial statements of the Fund within 90 days after the close of the period for which the report is being made, or as otherwise required by the 1940 Act. 

(b)<br> Not applicable.

---

| | |
|:---|:---|
| **Item 11.**<br>| **Additional Information.**  |

---

(a)<br> (1)<br>

None.

(2)<br> None.

(3)<br> Not applicable.

(4)<br> Not applicable.

(5)<br> None.

(c)<br> The Offer to Purchase, attached hereto as Exhibit (a)(1)(ii), is incorporated herein by reference in its entirety.

---

| | |
|:---|:---|
| **Item 12.**<br>| **Exhibits.**  |

---

---

| | |
|:---|:---|
| (a)(1)(i)  | Cover Letter to Offer to Purchase and Letter of Transmittal.  |
| (a)(1)(ii) | Offer to Purchase.  |
| (a)(1)(iii) | Forms of Letter of Transmittal.  |
| (a)(1)(iv) | Form of Letter from the Fund to Shareholders in Connection with the Fund's Acceptance of Shares.  |
| (a)(1)(v) | Form of Promissory Note.  |
| (a)(1)(vi) | Form of Notice of Withdrawal of Tender.  |
| (a)(2)-(5)  | Not applicable.  |
| (b) | Not applicable.  |
| (d) | Not applicable.  |
| (g) | Not applicable.  |
| (h) | Not applicable.  |
| 107 | Filing Fee Table. |

---

4<br>

------

#### SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| | | |
|:---|:---|:---|
| BLACKROCK PRIVATE CREDIT FUND  | BLACKROCK PRIVATE CREDIT FUND  | BLACKROCK PRIVATE CREDIT FUND  |
| By: | /s/ Diana Huffman  | /s/ Diana Huffman  |
|  | Name:  | Diana Huffman  |
|  | Title:  | Secretary |

---

Dated: May 11, 2026

5<br>

------

#### EXHIBIT INDEX

---

| | |
|:---|:---|
| **Exhibit** |  |
| [(a)(1)(i)](ny20072124x2_exa1i.htm) | Cover Letter to Offer to Purchase and Letter of Transmittal.  |
| [(a)(1)(ii)](ny20072124x2_exa1ii.htm) | Offer to Purchase.  |
| [(a)(1)(iii)](ny20072124x2_exa1iii.htm) | Forms of Letter of Transmittal.  |
| [(a)(1)(iv)](ny20072124x2_exa1iv.htm) | Form of Letter from the Fund to Shareholders in Connection with the Fund's Acceptance of Shares.  |
| [(a)(1)(v)](ny20072124x2_exa1v.htm) | Form of Promissory Note.  |
| [(a)(1)(vi)](ny20072124x2_exa1vi.htm) | Form of Notice of Withdrawal of Tender.  |
| [107](ny20072124x2_ex107.htm) | Filing Fee Table. |

---

6<br>

## Ex-99.A1I

#### Exhibit (a)(1)(i)

#### BLACKROCK PRIVATE CREDIT FUND <br>

#### c/o BlackRock Capital Investment Advisors, LLC <br>

#### 50 Hudson Yards <br>

#### New York, NY 10001
*If you do not want to sell your Fund Shares* 

<br> *interest at this time, please disregard this notice.* 

<br> *This is simply a notification of the Fund's repurchase offer.* 

May 11, 2026

Dear Shareholder:

This letter serves to inform you of important dates relating to a repurchase offer by BlackRock Private Credit Fund (the "Fund"). If you are not interested in tendering your shares of beneficial interest in the Fund ("Shares") for repurchase at this time, please disregard this notice and take no action.

Please note that the repurchase of Shares that have been issued after July 1, 2025 will be subject to an "early repurchase deduction" (except in the case of death, divorce or qualified disability of a shareholder), which will reduce your proceeds by 2%. In addition, the repurchase of Shares may also be subject to income and transfer taxes.

The tender offer period will begin on May 11, 2026 and end at 11:59 p.m., Eastern Time, on June 8, 2026. The purpose of the tender offer is to provide liquidity to shareholders of the Fund. Shares may be presented to the Fund for repurchase only by tendering them during one of the Fund's announced tender offers.

If you do not wish to sell your Shares for any reason, simply disregard this notice. **No action is required if you do not wish to sell any portion of your Shares at this time.**

Should you wish to tender all or some of your Shares during this tender offer period, please complete the enclosed Letter of Transmittal.

If you invest in the Fund through a financial intermediary, please send completed forms to your financial advisor / portfolio manager.

If you invest in the Fund <u>directly (not through a financial intermediary)</u>, please mail completed forms to the Fund's transfer agent at:

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FOR FIRST CLASS MAIL:*<br>*State Street Bank and Trust Company*<br>*Attn: BlackRock Alternative Funds*<br>*P.O. Box 5493* <br>*Boston, MA 02206* | E-MAIL: BLK_RegAlts_INQ@statestreet.com<br>FOR ADDITIONAL INFORMATION<br>CALL: 1-888-204-3956  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FOR OVERNIGHT MAIL:*<br>*State Street Bank and Trust Company*<br>*Attn: BlackRock Alternative Funds*<br>*1776 Heritage Drive*<br>*JAB/3*<br>*North Quincy, MA 02171* |  |

---

#### All Shareholders tendering Shares should carefully review their Letter of Transmittal and follow the delivery instructions therein.
All tenders of Shares must be received in good order by the Fund's Transfer Agent by 11:59 p.m., Eastern Time, on June 8, 2026.

If you have any questions, please refer to the attached Offer to Purchase document, which contains additional important information about the repurchase offer, or call 888-204-3956.

---

| |
|:---|
| Sincerely,  |
| BlackRock Private Credit Fund |

---

## Ex-99.A1Ii

#### **TABLE OF CONTENTS**

#### Exhibit (a)(1)(ii)

#### BLACKROCK PRIVATE CREDIT FUND <br>

#### c/o BlackRock Capital Investment Advisors, LLC <br>

#### 50 Hudson Yards <br>

#### New York, NY 10001

#### Offer to Purchase Up to 3,522,434 <br>

#### Shares of Beneficial Interest <br>

#### Dated May 11, 2026

#### The Offer and Withdrawal Rights Will Expire at 11:59 p.m., Eastern Time, on June 8, 2026, <br>

#### Unless the Offer is Extended
To the Shareholders of BlackRock Private Credit Fund:

Subject to the terms and conditions set forth in this offer to purchase ("Offer to Purchase") and the related Letter of Transmittal (which together with the Offer to Purchase and any amendments or supplements thereto constitutes the "Offer"), BlackRock Private Credit Fund, a non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the "1940 Act") and is organized as a Delaware statutory trust (the "Fund"), is offering to purchase up to 3,522,434 of its outstanding shares of beneficial interest (including Class S common shares of beneficial interest, Class D common shares of beneficial interest and Institutional common shares of beneficial interest, the "Shares") pursuant to tenders by shareholders of the Fund ("Shareholders") at a price equal to the net asset value per Share as of June 30, 2026 or a later date determined by the Fund if the Offer is extended (the "Valuation Date"). This Offer is currently scheduled to expire at 11:59 p.m., Eastern Time, on June 8, 2026 (the "Expiration Date"), but the Fund may extend this date; if it does, the Valuation Date may be changed. This Offer is being made to all Shareholders of the Fund and is not conditioned on any minimum amount of Shares being tendered, but is subject to certain conditions described below. Shares are not traded on any established trading market.

Shareholders should realize that the net asset value of the Shares tendered in this Offer will likely change between the most recent time net asset value was calculated and communicated to them and the Valuation Date (the relevant date for determining the value of the Shares tendered to the Fund for purposes of calculating the purchase price of such Shares) and such change could be material. The Fund generally determines the net asset value of the Shares as of the last calendar day of each month within 20 business days after the first calendar day of the following month. The most recently calculated net asset value for each class of the Shares can be found by going to www.bdebt.com. Shareholders should keep in mind that if they tender Shares in a tender offer with a Valuation Date that is within the 12-month period following the initial issue date of the Shares being tendered, such Shares will be subject to an "early repurchase deduction" (described further below) of 2% of the aggregate net asset value of the Shares repurchased. The early repurchase deduction will reduce the repurchase proceeds. For illustrative purposes, a Shareholder that acquires Shares on July 1 would not incur an early repurchase deduction for participating in a repurchase offer that has a valuation date of June 30 of the following year (or anytime thereafter).

Shareholders desiring to tender all or any portion of their Shares in accordance with the terms of the Offer should complete and sign the attached Letter of Transmittal and mail or fax it to the Fund's transfer agent, State Street Bank and Trust Company (the "Transfer Agent"), or the Shareholder's financial advisor, as applicable, in the manner provided for in the Letter of Transmittal and set forth in Section 4 "Procedure for Tenders" below.

#### IMPORTANT
*The Fund makes no recommendation to any Shareholder as to whether to tender or refrain from tendering Shares. Shareholders must make their own decisions whether to tender Shares and, if so, the portion of their Shares to tender.* 

*Because each Shareholder's investment decision is a personal one, based on its financial circumstances, no person has been authorized to make any recommendation on behalf of the Fund as to whether Shareholders should tender Shares pursuant to the Offer. No person has been authorized to give any information or to make any representations in connection with the Offer other than those contained herein or in the Letter of Transmittal. If given or made, such recommendation and such information and representations must not be relied on as having been authorized by the Fund.* 

------

#### **TABLE OF CONTENTS**
*This transaction has not been approved or disapproved by the Securities and Exchange Commission or the Commodity Futures Trading Commission nor has the Securities and Exchange Commission, the Commodity Futures Trading Commission, or any state securities commission passed on the fairness or merits of such transaction or on the accuracy or adequacy of the information contained in this document. Any representation to the contrary is unlawful.* 

Questions and requests for assistance and requests for additional copies of the Offer may be directed to the Transfer Agent:

State Street Bank and Trust Company

*FOR OVERNIGHT MAIL:* 

<br> *State Street Bank and Trust Company* 

<br> *Attn: BlackRock Alternative Funds* 

<br> *1776 Heritage Drive* 

<br> *JAB/3* 

<br> *North Quincy, MA 02171* 

*FOR FIRST CLASS MAIL:* 

<br> *State Street Bank and Trust Company* 

<br> *Attn: BlackRock Alternative Funds* 

<br> *P.O. Box 5493* 

<br> *Boston, MA 02206* 

Tel: (888) 204-3956 E-mail: BLK_RegAlts_INQ@statestreet.com

------

---

| | | |
|:---|:---|:---|
| [SUMMARY TERM SHEET](#tSUM) | [SUMMARY TERM SHEET](#tSUM) | &nbsp;&nbsp;[1](#tSUM) |
| [1.](#tBP) | [Background and Purpose of the Offer](#tBP) | &nbsp;&nbsp;[2](#tBP) |
| [2.](#tOP) | [Offer to Purchase and Price](#tOP) | &nbsp;&nbsp;[3](#tOP) |
| [3.](#tAT) | [Amount of Tender](#tAT) | &nbsp;&nbsp;[3](#tAT) |
| [4.](#tPT) | [Procedure for Tenders](#tPT) | &nbsp;&nbsp;[3](#tPT) |
| [5.](#tWR) | [Withdrawal Rights](#tWR) | &nbsp;&nbsp;[4](#tWR) |
| [6.](#tPP) | [Purchases and Payment](#tPP) | &nbsp;&nbsp;[4](#tPP) |
| [7.](#tCCO) | [Certain Conditions of the Offer](#tCCO) | &nbsp;&nbsp;[5](#tCCO) |
| [8.](#tCIA) | [Certain Information About the Fund](#tCIA) | &nbsp;&nbsp;[6](#tCIA) |
| [9.](#tTDP) | [Tender by DRIP Participants](#tTDP) | &nbsp;&nbsp;[7](#tTDP) |
| [10.](#tCFT) | [Certain U.S. Federal Income Tax Consequences](#tCFT) | &nbsp;&nbsp;[7](#tCFT) |
| [11.](#tMIS) | [Miscellaneous](#tMIS) | [10](#tMIS) |
| [FINANCIAL STATEMENTS](#tFS) | [FINANCIAL STATEMENTS](#tFS) | [10](#tFS) |

---

------

#### SUMMARY TERM SHEET
This is a summary of the features of the Offer. To understand the Offer fully and for a more complete discussion of the terms and conditions of the Offer, you should read carefully this entire Offer to Purchase and the related Letter of Transmittal.

&nbsp;&nbsp;&nbsp;&nbsp;• As disclosed in the Fund's prospectus dated April 24, 2026, as further supplemented and/or amended from time to time ("Prospectus"), the Fund may from time to time offer to repurchase a portion of its outstanding Shares pursuant to written tenders by Shareholders. Accordingly, the Fund is offering to purchase up to 3,522,434 Shares at a price equal to the net asset value per share (that is, the value of the Fund's total assets minus its total liabilities, divided by outstanding Shares) determined as of June 30, 2026 or such later date as may be determined by the Fund if the Offer is extended (the "Valuation Date"). The Shares subject to the Offer represent approximately 5% of the outstanding Shares as of March 31, 2026. The Offer, which begins on May 11, 2026, will remain open until 11:59 p.m., Eastern Time, on June 8, 2026 (the "Expiration Date"). The Fund reserves the right to adjust the Valuation Date to correspond to any extension of the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;• Each Shareholder whose Shares (or portion of them) have been accepted for repurchase will be bound by the terms of a promissory note entitling the shareholder to be paid an amount equal to the net asset value, determined as of the Valuation Date, of the repurchased Shares, subject to any early repurchase deduction (as described below) (a "Repurchase Instrument"). The Repurchase Instrument will be un-certificated, non-interest bearing, non-transferable and non-negotiable.

&nbsp;&nbsp;&nbsp;&nbsp;• **All Shares that were issued after July 1, 2025 that are tendered and purchased in this Offer will be subject to a 2% "early repurchase deduction." See Section 6 "Purchases and Payment".** 

&nbsp;&nbsp;&nbsp;&nbsp;• Shareholders may tender all or a portion of their Shares.

&nbsp;&nbsp;&nbsp;&nbsp;• If a Shareholder tenders Shares and the Fund purchases those Shares, the Fund will effect payment for those Shares in cash pursuant to the terms of the Repurchase Instrument promptly after the determination of the relevant net asset value per share is finalized.

&nbsp;&nbsp;&nbsp;&nbsp;• Other than the early withdrawal deduction described below (if applicable), the Fund does not expect to impose any charges on repurchases of Shares in the Fund.

&nbsp;&nbsp;&nbsp;&nbsp;• If you tender only a portion of your Shares, you must maintain a minimum account balance of at least $500 as of the Valuation Date. The Fund reserves the right to purchase all your Shares in the Fund if you tender less than all of your Shares and the number of Shares you tender would cause your account in the Fund to have a value lower than the required minimum balance. The Offer is being made to all Shareholders and is not conditioned on any minimum amount of Shares being tendered.

&nbsp;&nbsp;&nbsp;&nbsp;• If you are a participant in the Fund's dividend reinvestment plan ("DRIP") that elects to tender your Shares in full, any Shares issued to you under the DRIP subsequent to the Expiration Date of the tender offer will be considered part of your prior tender, and your participation in the DRIP will be automatically terminated as of the Expiration Date. Any distributions to be paid to you on or after the Expiration Date will be paid in cash on the scheduled distribution payment date.

&nbsp;&nbsp;&nbsp;&nbsp;• If you are a participant in the DRIP that elects to tender a portion of your Shares, your participation in the DRIP with respect to your Shares that were tendered will be terminated as of the Expiration Date. For the avoidance of doubt, your participation in the DRIP with respect to the Shares that were tendered will be terminated as of the Expiration Date regardless of whether all the Shares tendered are ultimately repurchased. Any distributions to be paid to you on or after the Expiration Date from the tendered Shares (whether or not the Shares were repurchased) will be paid in cash on the scheduled distribution payment date.

&nbsp;&nbsp;&nbsp;&nbsp;• If the Fund accepts the tender of any of your Shares, your proceeds will be funded from one or more of the following sources: cash on hand (including cash received from investments in the Fund), borrowings and/or proceeds from the sale of portfolio holdings.

&nbsp;&nbsp;&nbsp;&nbsp;• Additional repurchases will be made at such times and on such terms as may be determined by the Board of Trustees of the Fund (the "Board"). BlackRock Capital Investment Advisors, LLC, the Fund's

1<br>

------

#### **TABLE OF CONTENTS**
investment adviser (the "Adviser"), expects that it will generally recommend to the Board that the Fund offer to repurchase a portion of its outstanding Shares four times each year, having valuation dates on or about September 30, December 31, March 31 and June 30, but the Fund is not required to make any such offer.

&nbsp;&nbsp;&nbsp;&nbsp;• Following this summary is a formal notice of the Offer, which remains open until the Expiration Date, unless extended. If you elect to tender your Shares, you have the right to change your mind and withdraw your tendered Shares at any time until the Expiration Date or, if such tendered Shares have not been accepted by the Fund, at any time on or after June 30, 2026. If you would like to tender your Shares, you must complete the Letter of Transmittal enclosed with the Offer to Purchase, and return it as instructed in the Letter of Transmittal either (i) to the Transfer Agent, Attention: BlackRock Private Credit Fund, by (a) mail at State Street Bank and Trust Company, Attn: BlackRock Alternative Funds, 1776 Heritage Drive, JAB/3, North Quincy, MA 02171, or (b) by e-mail to BLK_RegAlts_INQ@statestreet.com; or (ii) to your financial advisor, as directed. If you choose to e-mail the Letter of Transmittal, please mail the original promptly after you e-mail it. Your properly completed mailed or e-mailed Letter of Transmittal must be received prior to the Expiration Date. If you decide to tender, it is your responsibility to, and the Fund strongly recommends that you do, confirm receipt of your Letter of Transmittal with the Transfer Agent by calling (888) 204-3956, Monday through Friday, except holidays, during normal business hours of 9:00 a.m. to 5:00 p.m. (Eastern Time). All Shareholders tendering Shares should carefully review their Letter of Transmittal and follow the delivery instructions therein.

&nbsp;&nbsp;&nbsp;&nbsp;• The net asset value of your Shares will likely change between the most recent time the net asset value was calculated and communicated to you and the Valuation Date (the date when the value of your investment will be determined for purposes of calculating the purchase price of your Shares). If you would like to obtain the estimated net asset value of your Shares, visit the Fund's website at www.bdebt.com.

&nbsp;&nbsp;&nbsp;&nbsp;• Please note that just as you have the right to withdraw your tender of Shares, the Fund has the right to cancel, amend or postpone this offer at any time on or before the Expiration Date.

&nbsp;&nbsp;&nbsp;&nbsp;• Each Shareholder whose Shares (or portion thereof) have been accepted for repurchase will continue to be a Shareholder of the Fund until the Valuation Date (and thereafter if not all of its Shares are repurchased) and may exercise his or her voting rights with respect to the repurchased Shares until the Valuation Date. Following the Valuation Date, a Shareholder whose Shares have been accepted for repurchase shall retain, with respect to such repurchased Shares, all rights to inspect the books and records of the Fund and to receive financial and other reports relating to the Fund until the payment date, but shall have no other rights of a Shareholder (including, without limitation, any voting rights) with respect to such repurchased Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Background and Purpose of the Offer. The purpose of the Offer is to provide liquidity to Shareholders. Because there is no secondary trading market for Shares, the Board has determined, after consideration of various matters, that the Offer is in the best interests of Shareholders in order to provide liquidity for Shares as contemplated in the Prospectus. The Board intends to consider the continued desirability of the Fund making an offer to purchase Shares four times each year, but the Fund is not required to make any such offer.

The purchase of Shares pursuant to the Offer will have the effect of increasing the proportionate interest in the Fund of Shareholders who do not tender Shares. Shareholders who retain their Shares may be subject to increased risks that may possibly result from the reduction in the Fund's aggregate assets resulting from payment for the Shares tendered. These risks include the potential for greater volatility due to decreased diversification. A reduction in the aggregate assets of the Fund may result in Shareholders who do not tender Shares bearing higher costs to the extent that certain expenses borne by the Fund are relatively fixed and may not decrease if assets decline. These effects may be reduced or eliminated to the extent that additional purchases of Shares are made by new and existing investors from time to time, although there can be no assurances that such new or additional purchases will occur.

Shares that are tendered to the Fund in connection with the Offer, if accepted for repurchase, will be repurchased, resulting in a change in the income ratio and an increase in the expense ratios of Shares owned by Shareholders remaining in the Fund (assuming no further issuances of Shares).

2<br>

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Offer to Purchase and Price. The Fund will purchase, upon the terms and subject to the conditions of the Offer, up to 3,522,434 of those outstanding Shares that are properly tendered by, and not withdrawn (in accordance with Section 5 "Withdrawal Rights" below) before, the Expiration Date.

The Fund reserves the right to extend, amend or cancel the Offer as described in Sections 3 and 7 below. The purchase price of a Share tendered will be its net asset value as of the Valuation Date, payable as set forth in Section 6. The Fund reserves the right to adjust the Valuation Date to correspond with any extension of the Offer.

As of the close of business on March 31, 2026, there were (i) approximately 65,319,352 Institutional Shares issued and outstanding, with a net asset value per share of $23.52, (ii) approximately 5,032,831 Class S Shares issued and outstanding, with a net asset value per share of $23.52 and (iii) approximately 96,496 Class D Shares issued and outstanding, with a net asset value per share of $23.52. Shareholders may obtain monthly estimated net asset value information until the Expiration Date of the Offer at www.bdebt.com. The net asset value of the Shares tendered by Shareholders likely will change between the most recent time net asset value was calculated and communicated to you and the Valuation Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Amount of Tender. Subject to the limitations set forth below, Shareholders may tender all or a portion of their Shares. If you tender only a portion of your Shares, you must maintain a minimum account balance of at least $500 as of the Valuation Date. The Fund reserves the right to purchase all your Shares in the Fund if you tender less than all of your Shares and the number of Shares you tender would cause your account in the Fund to have a value lower than the required minimum balance. The Offer is being made to all Shareholders and is not conditioned on any minimum amount of Shares being tendered.

If less than 3,522,434 Shares are properly tendered pursuant to the Offer and not withdrawn, the Fund will, on the terms and subject to the conditions of the Offer, purchase all of the Shares so tendered unless the Fund elects to cancel or amend the Offer, or postpone acceptance of tenders made pursuant to the Offer, as provided in Section 7 "Certain Conditions of the Offer" below. If more than 3,522,434 Shares are duly tendered to the Fund before the expiration of the Offer and not withdrawn, pursuant to Section 5 "Withdrawal Rights" below, the Fund will accept Shares tendered on or before the Expiration Date for payment on a pro rata basis based on the number of tendered Shares. The unaccepted portion of any tender of Shares made by a Shareholder pursuant to this Offer shall not be automatically carried forward or given priority in connection with any future tender offer made by the Fund, but any Shareholder that wishes to have the Fund repurchase Shares that were not accepted for repurchase in connection with this Offer may again tender those Shares in connection with, and subject to the terms and conditions of, any future tender offer made by the Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Procedure for Tenders. Shareholders wishing to tender Shares pursuant to the Offer must complete and execute the Letter of Transmittal in accordance with the instructions on the first page of such Shareholder's Letter of Transmittal. The completed and executed Letter of Transmittal must be received by the specified agent by 11:59 p.m., Eastern Time, on the Expiration Date.

With respect to Shareholders that are required to submit their Letter of Transmittal to the Transfer Agent, Attention: BlackRock Private Credit Fund, submissions may be made either (a) by mail at State Street Bank, Attn: BlackRock Alternative Funds, 1776 Heritage Drive, JAB/3, North Quincy, MA 02171, or (b) by e-mail to BLK_RegAlts_INQ@statestreet.com, Attention: BlackRock Private Credit Fund. The Fund recommends that all documents be submitted by certified mail, return receipt requested, or by e-mail. A Shareholder choosing to e-mail a Letter of Transmittal must also mail the original completed and executed Letter of Transmittal promptly thereafter.

Shareholders wishing to confirm receipt of a Letter of Transmittal may contact the agent specified in the instructions therein. ***The method of delivery of any documents is at the election and complete risk of the Shareholder tendering Shares, including, but not limited to, the failure to receive any Letter of Transmittal or other document submitted by facsimile transmission.*** All questions as to the validity, form, eligibility (including time of receipt) and acceptance of tenders will be determined by the Fund, in its sole discretion, and its determination shall be final and binding. The Fund reserves the absolute right to reject any or all tenders (i) determined by it not to be in appropriate form or (ii) for which the acceptance of, or payment for, would, in the opinion of counsel for the Fund, be unlawful. The Fund also reserves the absolute right to waive any of the conditions of the Offer or any defect in any tender with respect to any particular Shares or any particular Shareholder (including, without limitation, the conditions relating to the dates on which Shares must be tendered or withdrawn), and the Fund's interpretation of the terms and conditions of the Offer will be final and binding. Unless waived, any defects or irregularities in connection with tenders must be cured within such time as the Fund shall

3<br>

------

determine. Tenders will not be deemed to have been made until the defects or irregularities have been cured or waived. None of the Fund, the Board, the Adviser, or any of their agents is obligated to give notice of any defects or irregularities in tenders, nor shall any of them incur any liability for failure to give such notice.

By submitting a Letter of Transmittal, and in accordance with the terms and conditions of the Offer, a tendering shareholder shall be deemed to represent and warrant that: (a) the tendering shareholder has full power and authority to tender, sell, assign and transfer the tendered Shares (and any and all dividends, distributions, other Shares or other securities or rights declared, paid or distributed in respect of such Shares that are declared, paid or distributed in respect of a record date occurring on or after the date on which the Fund accepts the Shares for repurchase (collectively, "Distributions")); (b) when and to the extent the Fund accepts the Shares for purchase, the Trust will acquire good, marketable and unencumbered title thereto and to all Distributions, free and clear of all liens, restrictions, charges, proxies, encumbrances or other obligations relating to their sale or transfer, and not subject to any adverse claim; (c) on request, the tendering shareholder will execute and deliver any additional documents deemed by the Transfer Agent or the Trust to be necessary or desirable to complete the sale, assignment and transfer of the tendered Shares (and all Distributions); and (d) the tendering shareholder has read and agreed to all of the terms of the Offer, including this Offer to Purchase and the Letter of Transmittal.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Withdrawal Rights. Any Shareholder tendering Shares pursuant to this Offer may withdraw tendered Shares at any time before the Expiration Date or, if the Fund has not accepted such tendered Shares, on or after June 30, 2026. A form to use to give notice of withdrawal is enclosed with the Offer to Purchase. To be effective, any notice of withdrawal must be timely received by the agent specified in the instructions to the Notice of Withdrawal. All questions as to the form and validity (including time of receipt) of notices of withdrawal will be determined by the Fund, in its sole discretion, and such determination shall be final and binding. Shares properly withdrawn shall not thereafter be deemed to be tendered for purposes of the Offer. However, withdrawn Shares may be re-tendered prior to the Expiration Date by following the procedures for tenders described above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. Purchases and Payment. For purposes of the Offer, the Fund will be deemed to have accepted Shares that are tendered if and when it gives written notice to the tendering Shareholder of its election to purchase such Shares.

Each Shareholder whose Shares (or portion of them) have been accepted for repurchase will be bound by the terms of a Repurchase Instrument entitling the Shareholder to be paid an amount equal to the value, determined as of the Valuation Date, of the repurchased Shares, subject to any early repurchase deduction (as described below). The Repurchase Instrument will be un-certificated, non-interest bearing, non-transferable and nonnegotiable. The Repurchase Instrument will be held for each shareholder in an account with State Street Bank and Trust Company, Inc., the Fund's transfer agent and agent designated for this purpose. If a Shareholder wishes to receive a copy of the Repurchase Instrument, the shareholder may contact BLK_RegAlts_INQ@statestreet.com to request that a copy be delivered to such Shareholder.

Payment under the Repurchase Instrument will be made in cash in a single installment on or before 30 days after the Valuation Date by wire transfer to the account designated by the Shareholder. The Repurchase Instrument may be prepaid, without premium, penalty or notice, at any time.

Other than the early repurchase deduction described below (if applicable), the Fund does not expect to impose any charges on repurchases of Shares in the Fund.

Each Shareholder whose Shares (or portion thereof) have been accepted for repurchase will continue to be a Shareholder of the Fund until the Valuation Date (and thereafter if not all of its Shares are repurchased) and may exercise his or her voting rights with respect to the repurchased Shares until the Valuation Date. Following the Valuation Date, a Shareholder whose Shares have been accepted for repurchase shall retain, with respect to such repurchased Shares, all rights to inspect the books and records of the Fund and to receive financial and other reports relating to the Fund until the payment date, but shall have no other rights of a Shareholder (including, without limitation, any voting rights) with respect to such repurchased Shares.

As described in the Prospectus, any Shareholder that sells Shares in a repurchase offer that have not been outstanding for at least one year will be repurchased at 98% of the aggregate net asset value of the Shares repurchased by the Fund; this reduction is referred to herein as an "early repurchase deduction." Payment of the early repurchase deduction will be made by reducing the repurchase proceeds. The early repurchase deduction will

4<br>

------

be retained by the Fund for the benefit of remaining Shareholders. Shares repurchased will be treated as having been repurchased on a "first in—first out" basis. Therefore, the portion of Shares repurchased will be deemed to have been taken from the earliest Shares purchased by such Shareholder.

A Shareholder who tenders some but not all of such Shareholder's Shares for repurchase will be required to maintain a minimum account balance of $500 in the Fund. Such minimum account balance requirement may be waived by the Fund, in its sole discretion. The Fund reserves the right to reduce the number of Shares to be repurchased from a Shareholder so that the required account balance is maintained.

The Fund expects that the purchase price for Shares acquired pursuant to the Offer to Purchase will be derived from cash on hand (including cash received from investments in the Fund), borrowings and/or proceeds from the sale of portfolio holdings. Payment for repurchased shares may require the Fund to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. The Fund intends to take measures, subject to policies as may be established by our Board, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares. None of the Fund, the Adviser or the Board or any person controlling the Fund, the Adviser or the Board has determined at this time to borrow funds to purchase Shares tendered in connection with the Offer. Depending on the dollar amount of Shares tendered and prevailing general economic and market conditions, the Fund, in its sole discretion, may decide to borrow money to fund all or a portion of the purchase amount for Shares, subject to compliance with applicable law. In this regard, a wholly owned subsidiary of the Fund has entered into a $200 million combined revolving credit and term loan facility with PNC Bank, National Agent as facility agent (the "Credit Facility"). The Credit Facility matures on June 3, 2032 and general bears interest at three-month Term SOFR. Payment by the Fund of amounts owed to Shareholders who tender their Shares in this repurchase offer is not contingent upon the availability of any financing option.

The repurchase of Shares is subject to regulatory requirements imposed by the SEC. The Fund's repurchase procedures are intended to comply with such requirements. However, in the event that the Board determines that modification of the repurchase procedures described above is required or appropriate, the Board will adopt revised repurchase procedures as necessary to ensure the Fund's compliance with applicable regulations or as the Board in its sole discretion deems appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. Certain Conditions of the Offer. The Fund reserves the right, at any time and from time to time, to extend the period of time during which the Offer is pending by notifying Shareholders of such extension. If the Fund elects to extend the tender period, the Valuation Date may occur after June 30, 2026 and in that case, for purposes of determining the purchase price for tendered Shares, the net asset value of such Shares will be determined approximately one month after the actual Valuation Date. During any such extension, all Shares previously tendered and not withdrawn will remain subject to the Offer. The Fund also reserves the right, at any time and from time to time, up to and including acceptance of tenders pursuant to the Offer, to: (a) cancel the Offer and in the event of such cancellation, not to purchase or pay for any Shares tendered pursuant to the Offer; (b) amend the Offer; or (c) postpone the acceptance of Shares tendered. If the Fund determines to amend the Offer or to postpone the acceptance of Shares tendered, it will, to the extent necessary, extend the period of time during which the Offer is open as provided above and will promptly notify Shareholders.

Please note that just as you have the opportunity to withdraw shares that you have tendered under certain circumstances, the Fund has the right to cancel, amend or postpone the Offer at any time before accepting tendered Shares. The Fund may cancel the Offer, amend the Offer or postpone the acceptance of tenders made pursuant to the Offer if: (a) the Fund would not be able to liquidate portfolio securities in a manner that is orderly and consistent with the Fund's investment objectives and policies in order to purchase Shares tendered pursuant to the Offer; (b) there is, in the Board's judgment, any (i) legal action or proceeding instituted or threatened challenging the Offer or that otherwise would have a material adverse effect on the Fund, (ii) declaration of a banking moratorium by Federal or state authorities or any suspension of payment by banks in the United States or New York State that is material to the Fund, (iii) limitation imposed by Federal or state authorities on the extension of credit by lending institutions, (iv) suspension of trading on any organized exchange or over-the-counter market where the Fund has a material investment, (v) commencement of war, armed hostilities or other international or national calamity directly or indirectly involving the United States that is material to the Fund, (vi) material decrease in the estimated net asset value of the Fund from the estimated net asset value of the Fund as of the commencement of the Offer, or (vii) other event or condition that would have a material adverse effect on the Fund or its Shareholders if Shares tendered

5<br>

------

pursuant to the Offer were purchased; or (c) the Independent Trustees of the Fund determine that it is not in the best interest of the Fund to purchase Shares pursuant to the Offer. However, there can be no assurance that the Fund will exercise its right to extend, amend or cancel the Offer or to postpone acceptance of tenders pursuant to the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. Certain Information About the Fund. The Fund is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act and is organized as a Delaware statutory trust. The principal executive office of the Fund is located at 50 Hudson Yards, New York, NY 10001 and the telephone number is (212) 810-5300. Shares are not traded on any established trading market.

The Fund does not have any plans or proposals that relate to or would result in: (a) the acquisition by any person of additional Shares (other than the Fund's intention to accept purchases for Shares from time to time, the DRIP or otherwise in the discretion of the Fund) or the disposition of Shares (except for periodic discretionary solicitations of tender offers); (b) an extraordinary transaction, such as a merger, reorganization or liquidation, involving the Fund; (c) any material change in the present distribution policy or indebtedness or capitalization of the Fund; (d) any change in the identity of the investment adviser or Trustees of the Fund, or in the management of the Fund including, but not limited to, any plans or proposals to change the number or the term of the Trustees, to change any material term of the investment advisory arrangements with the Adviser; (e) a sale or transfer of a material amount of assets of the Fund (other than as the Trustees determine may be necessary or appropriate to fund any portion of the purchase price for Shares acquired pursuant to this Offer to Purchase or in connection with the ordinary portfolio transactions of the Fund); (f) any other material change in the Fund's structure or business, including any plans or proposals to make any changes in its fundamental investment policy for which a vote would be required by Section 13 of the 1940 Act; or (g) any changes in the Fourth Amended and Restated Agreement and Declaration of Trust, as amended, Bylaws, as amended, or Prospectus or other actions that may impede the acquisition of control of the Fund by any person.

Based on the number of Shares outstanding as of March 31, 2026, the following persons own the number of Shares indicated in the below table:

---

| | | |
|:---|:---|:---|
| **Person** | **Shares** | **Percentage of the Fund's** <br>**Outstanding Shares**  |
| BlackRock Financial Management, Inc. | 5998843 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.515%  |
| Eric J. Draut | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1077 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.002%  |
| John Perlowski | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| Andrea Petro | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| Maureen Usifer | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| &nbsp;&nbsp;Philip Tseng | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1009 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.001%  |
| Charles C. S. Park | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| Jason Mehring | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;682 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.001%  |
| Erik L. Cuellar | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| &nbsp;&nbsp;Patrick Wolfe | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0%  |
| Dan Worrell | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4036 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.006%  |
| Diana Huffman | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0% |

---

Based on information available to the Fund, none of the persons listed above intends to tender any of his or her Shares in the Offer.

During the past sixty (60) days, the Fund issued an aggregate of approximately 3,353,915 Shares, including Shares issued pursuant to the DRIP, for net proceeds of approximately $78,916,138.16.

In connection with the completion of the Fund's tender offer that commenced on January 30, 2026, the Fund repurchased on or about February 27, 2026, 2,957,174 of its outstanding shares of beneficial interest (including Class I common shares of beneficial interest, Class S common shares of beneficial interest, and Class D common shares of beneficial interest), at a purchase price of $23.52 per share, the net asset value per share as of March 31, 2026, pursuant to the terms of such tender offer, as set forth in the Schedule TO-I filed by the Fund with the SEC on January 30, 2026. The payment of the purchase price of the Shares tendered was made in the form of non-interest bearing, non-transferable promissory notes issued to the Shareholders whose tenders were accepted for purchase by the Fund in accordance with the terms of the Offer. The promissory notes were held by the Fund's transfer agent on

6<br>

------

behalf of each tendering shareholder. Pursuant to the promissory notes, on or before April 30, 2026, the Fund paid to the tendering Shareholders a total of $69,530,706.73 an amount equal to the aggregate net asset value of the Shares as of the Valuation Date, less the early repurchase deduction, as applicable.

There have been no other transactions in Shares effected during the past sixty (60) days by the Fund, and the Adviser, BlackRock Financial Management, Inc., or any Trustee or officer of the Fund, or any person controlling the Fund or the Adviser.

As of March 31, 2026, to the knowledge of the Fund, no person owned beneficially or of record more than 5% of the shares of the Fund, except for the following:

---

| | | |
|:---|:---|:---|
| BlackRock Private Credit Fund iCapital Offshore Access Fund, L.P. - Cash | 32712748 | 46.435%  |
| BlackRock Private Credit Fund iCapital Offshore Access Fund, L.P. - Reinvest | 13065303 | 18.546%  |
| BlackRock Financial Management, Inc. | &nbsp;&nbsp;5998843 | &nbsp;&nbsp;8.515% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. Tender by DRIP Participants. If you are a participant in the Fund's DRIP that elects to tender your Shares in full, any Shares issued to you under the DRIP subsequent to the Expiration Date of the tender offer will be considered part of your prior tender, and your participation in the DRIP will be automatically terminated as of the Expiration Date. Any distributions to be paid to you on or after the Expiration Date will be paid in cash on the scheduled distribution payment date.

If you are a participant in the DRIP that elects to tender a portion of your Shares, your participation in the DRIP with respect to your Shares that were tendered will be terminated as of the Expiration Date. For the avoidance of doubt, your participation in the DRIP with respect to the Shares that were tendered will be terminated as of the Expiration Date regardless of whether all the Shares tendered are ultimately repurchased. Any distributions to be paid to you on or after the Expiration Date from the tendered Shares (whether or not the Shares were repurchased) will be paid in cash on the scheduled distribution payment date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. Certain U.S. Federal Income Tax Consequences. The following discussion is a general summary of the U.S. federal income tax consequences of the purchase of Shares by the Fund from Shareholders pursuant to the Offer. This summary is based on U.S. federal income tax law as of the date hereof, including the Internal Revenue Code of 1986, as amended (the "Code"), applicable Treasury regulations, Internal Revenue Service ("IRS") rulings, judicial authority and current administrative rulings and practice, all of which are subject to change, possibly with retroactive effect. There can be no assurance that the IRS would not assert, or that a court would not sustain, a position contrary to any of those set forth below, and the Fund has not obtained, nor does the Fund intend to obtain, a ruling from the IRS or an opinion of counsel with respect to any of the consequences described below. Shareholders should also consult their own tax advisers regarding their particular situation and the potential tax consequences to them of a purchase of their Shares by the Fund pursuant to the Offer, including potential state, local and foreign taxation, as well as any applicable transfer taxes.

Except where noted, this discussion deals only with Shares held as capital assets and does not deal with all tax consequences that may be relevant to Shareholders in light of their particular circumstances or to Shareholders subject to special tax rules (including, without limitation, partnerships or other pass-through entities (and investors therein), dealers or traders in securities, financial institutions, tax-exempt organizations, insurance companies, U.S. expatriates, persons liable for the alternative minimum tax, persons holding Shares as a part of a hedging, conversion or constructive sale transaction or a straddle, nonresident alien individuals present in the United States for more than 182 days during the taxable year in which their Shares are repurchased pursuant to the Offer or U.S. Shareholders (as defined below) whose functional currency is not the U.S. dollar). In addition, this discussion does not address any considerations in respect of any withholding required pursuant to the Foreign Account Tax Compliance Act of 2010 (including the Treasury regulations promulgated thereunder and intergovernmental agreements entered into in connection therewith).

As used herein, the term "U.S. Shareholder" refers to a Shareholder who, for U.S. federal income tax purposes, is (i) an individual citizen or resident of the United States, (ii) a corporation created or organized in or under the laws of the United States or any State thereof or the District of Columbia, (iii) an estate the income of which is subject to U.S. federal income tax regardless of the source of such income, or (iv) a trust if (a) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more U.S. persons (as defined in the Code) have the authority to control all substantial decisions of the trust or (b) the trust has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person. The term

7<br>

------

"Non-U.S. Shareholder" refers to a Shareholder who, for U.S. federal income tax purposes, is an individual, corporation, estate or trust and is not a U.S. Shareholder. Except for the discussion under "Non-U.S. Shareholders" and "Backup Withholding," the following discussion is limited to U.S. Shareholders.

**Sale or Exchange of Shares. Under Section 302(b) of the Code, a Shareholder whose Shares are repurchased pursuant to the Offer generally will be treated as having sold the Shares and will recognize gain or loss for U.S. federal income tax purposes, so long as either (a) such Shareholder tenders, and the Fund repurchases, all of such Shareholder's Shares (i.e., reduces such Shareholder's percentage ownership of the Fund to 0%), (b) such Shareholder meets numerical safe harbors with respect to percentage voting interest and reduction in ownership of the Fund following the completion of the Offer, or (c) the tender otherwise results in a distribution that is "not essentially equivalent to a dividend," which determination depends on a Shareholder's particular facts and circumstances, including the initial size of and extent to which a Shareholder's ownership percentage interest in the Fund is reduced. For these purposes, a shareholder's ownership of the Fund is determined after applying the ownership attribution rules under Section 318 of the Code. The gain or loss recognized by a Shareholder in such case generally will equal the difference between the price paid by the Fund for the Shares pursuant to the Offer and the Shareholder's adjusted tax basis in the Shares sold. A tendering Shareholder's gain or loss will generally be capital gain or loss, and will generally be treated as long-term capital gain or loss if the Shares have been held for more than one year or as short-term capital gain or loss if the Shares have been held for one year or less. For these purposes, a Shareholder's holding period in Shares repurchased pursuant to the Offer should terminate as of the Valuation Date. If a Shareholder realizes a gain upon the sale of its Shares and payment for the Shares is received after the close of the taxable year of the Shareholder in which the Valuation Date occurs, it is expected that, unless the Shareholder elects otherwise, the Shareholder will generally recognize such gain in the taxable year in which the proceeds are received. In such a case, the Shareholder should consult its tax advisor regarding the potential application of the "installment sale" rules to its sale of Shares pursuant to the Offer, including any imputed interest or interest charge thereunder. The maximum U.S. federal income tax rate applicable to short-term capital gains recognized by a non-corporate Shareholder is currently the same as the applicable ordinary income rate. In addition, the Code generally imposes a 3.8% Medicare contribution tax on the net investment income of certain individuals, estates and trusts to the extent their income exceeds certain threshold amounts. For these purposes, "net investment income" generally includes, among other things, (i) distributions paid by the Fund of net investment income and capital gains, and (ii) any net gain from the sale, exchange or other taxable disposition of the Shares.** 

In the event that a tendering Shareholder's ownership (or deemed ownership under Section 318 of the Code) of Shares of the Fund is not reduced to the extent required under the tests described above, such Shareholder would be deemed to receive a distribution from the Fund under Section 301 of the Code with respect to the Shares held by the Shareholder (a "Section 301 distribution"). Such distribution, which would equal the price paid by the Fund to such Shareholder for the Shares sold, would be taxable as a dividend to the extent of the Fund's current or accumulated earnings and profits allocable to such distribution, with the excess treated as a return of capital reducing the Shareholder's tax basis in the Shares, and thereafter as capital gain. If any amounts received by a Shareholder are treated as a dividend, the tax basis (after any adjustment for a return of capital) in the Shares sold pursuant to the Offer will generally be transferred to any remaining Shares held by the Shareholder. It is not expected that any amount treated as a dividend will be eligible for the dividends received deduction allowed to corporations or for the reduced U.S. federal income tax rates that are currently imposed on certain "qualified dividend income" received by non-corporate Shareholders.

Provided that no tendering Shareholder is treated as receiving a Section 301 distribution as a result of the Offer, Shareholders whose percentage ownership of the Fund increases as a result of the Offer will not be treated as realizing constructive distributions by virtue of that increase. In the event that any tendering Shareholder is deemed to receive a Section 301 distribution as a result of the Offer, it is possible that Shareholders whose percentage ownership of the Fund increases as a result of the Offer, including Shareholders who do not tender any Shares pursuant to the Offer, will be deemed to receive a constructive distribution under Section 305(c) of the Code in an amount determined by the increase in their percentage ownership of the Fund as a result of the Offer. Such constructive distribution would be treated as a dividend to the extent of the Fund's current or accumulated earnings and profits allocable to it.

Under the "wash sale" rules under the Code, provided the tender of Shares pursuant to the Offer is treated as a sale or exchange (and not a distribution as described above), loss recognized on Shares sold pursuant to the Offer will ordinarily be disallowed to the extent the Shareholder acquires other Shares of the Fund (whether through

8<br>

------

automatic reinvestment of dividends or otherwise) or substantially identical stock or securities within 30 days before or after the date the tendered Shares are treated as purchased pursuant to the Offer. In that event, the basis and holding period of the Shares (or substantially identical stock or securities) acquired will be adjusted to reflect the disallowed loss. Any loss realized by a Shareholder on the sale of Shares held by the Shareholder for six months or less will be treated for U.S. federal income tax purposes as a long-term capital loss to the extent of any distributions or deemed distributions of long-term capital gains received by the Shareholder with respect to such Shares. A Shareholder's ability to utilize capital losses may be limited under the Code.

**Taxation of Non-U.S. Shareholders. Generally, if a Non-U.S. Shareholder's sale of Shares pursuant to the Offer is respected as a sale or exchange for U.S. federal income tax purposes pursuant to Section 302(b) of the Code (as discussed above), any gain realized by the Non-U.S. Shareholder will not be subject to U.S. federal income tax or to any U.S. tax withholding, provided that such gain is not effectively connected with a trade or business carried on in the United States by the Non-U.S. Shareholder. If, however, all or a portion of the proceeds received by a tendering Non-U.S. Shareholder is treated for U.S. federal income tax purposes as a distribution by the Fund that is a dividend, or if a Non-U.S. Shareholder is otherwise treated as receiving a deemed distribution that is a dividend by reason of the Shareholder's increase in its percentage ownership of the Fund resulting from other Shareholders' sale of Shares pursuant to the Offer, then, as discussed in greater detail in the Fund's Prospectus, absent a statutory exemption, the dividend received or deemed received by the Non-U.S. Shareholder will be subject to a U.S. withholding tax of 30% (or a lower treaty rate). If any gain or dividend income realized in connection with the tender of Shares by a Non-U.S. Shareholder is effectively connected with a trade or business carried on in the United States by the Non-U.S. Shareholder, such gain or dividend will generally be taxed at the regular rates applicable to U.S. Shareholders. In addition, if the Non-U.S. Shareholder is a non-U.S. corporation, it may be subject to an additional branch profits tax of 30% (or a lower treaty rate) on its effectively connected income. In order to qualify for an exemption from withholding for effectively connected income or for lower withholding tax rates under income tax treaties, or to establish an exemption from backup withholding, a Non-U.S. Shareholder must comply with special certification and filing requirements relating to its non-U.S. status (including, in general, furnishing an IRS Form W-8ECI, W-8BEN or W-8BEN-E, as applicable, or any substitute form). Because an applicable withholding agent may not be able to determine if a particular Non-U.S. Shareholder qualifies for sale or exchange treatment pursuant to Section 302(b) of the Code, such agent may withhold U.S. federal income tax equal to 30% of the gross payments payable to a Non-U.S. Shareholder unless the agent determines that an exemption or a reduced rate of withholding is available as discussed above. However, a Non-U.S. Shareholder may be eligible to obtain a refund of all or a portion of any tax withheld if such Non-U.S. Shareholder establishes that it qualifies for sale or exchange treatment pursuant to Section 302(b) of the Code or is otherwise able to establish that no tax or a reduced amount of tax is due. See the section of the Fund's Prospectus entitled "Certain U.S. Federal Income Tax Consequences—Taxation of Non-U.S. Shareholders" for further information concerning the taxation of Non-U.S. Shareholders. Non-U.S. Shareholders are urged to consult their tax advisors regarding the application of U.S. federal income tax rules, including withholding, to their tender of Shares.** 

**Backup Withholding. The Fund generally is required to withhold and remit to the U.S. Treasury a percentage of the taxable distributions and redemption proceeds paid to any U.S. Shareholder who fails to properly furnish the Fund with a correct taxpayer identification number and a certification that such Shareholder is not subject to backup withholding (generally, through the provision of a properly executed IRS Form W-9). A Non-U.S. Shareholder generally can establish an exemption from backup withholding by certifying as to its foreign status (generally, through the provision of a properly executed IRS Form W-8BEN, W-8BEN-E or other applicable Form W-8).** 

Shareholders should provide the Fund with a completed IRS Form W-9, W-8BEN or W-8BEN-E, as applicable, or other appropriate form in order to avoid backup withholding on the payment they receive from the Fund regardless of how they are taxed with respect to their tendered Shares. Backup withholding is not an additional tax and any amount withheld may be credited against a Shareholder's U.S. federal income tax liability, and may entitle the Shareholder to a refund, provided in each case that the appropriate information is furnished to the IRS.

**Other Tax Consequences. The Fund's purchase of Shares in the Offer may directly result in, or contribute to a subsequent, limitation on the Fund's ability to use capital loss carryforwards to offset future gains. Therefore, in certain circumstances, Shareholders who remain Shareholders following completion of the Offer may pay taxes sooner, or pay more taxes, than they would have had the Offer not occurred.** 

9<br>

------

Payments for repurchased Shares may require the Fund to liquidate all or a portion of its portfolio holdings. Such action could give rise to increased taxable distributions to Shareholders, including distributions of ordinary income or short-term capital gains taxable to individuals as ordinary income.

Under Treasury regulations directed at tax shelter activity, if a Shareholder recognizes a loss of $2 million or more for an individual Shareholder or $10 million or more for a corporate Shareholder, such Shareholder must file with the IRS a disclosure statement on Form 8886. Direct holders of portfolio securities are in many cases excepted from this reporting requirement, but under current guidance, shareholders of a regulated investment company ("RIC"), such as the Fund, are not excepted. Future guidance may extend the current exception from this reporting requirement to shareholders of most or all RICs. The fact that a loss is reportable under these regulations does not affect the legal determination of whether the taxpayer's treatment of the loss is proper. Shareholders should consult their own tax advisers concerning any possible disclosure obligation with respect to their disposition of Shares pursuant to the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. Miscellaneous . The Offer is not being made to, nor will tenders be accepted from, Shareholders in any jurisdiction in which the Offer or its acceptance would not comply with the securities or Blue Sky laws of such jurisdiction. The Fund is not aware of any jurisdiction in which the Offer or tenders pursuant thereto would not be in compliance with the laws of such jurisdiction. However, the Fund reserves the right to exclude Shareholders from the Offer in any jurisdiction in which it is asserted that the Offer cannot lawfully be made. The Fund believes such exclusion is permissible under applicable laws and regulations, provided the Fund makes a good faith effort to comply with any state law deemed applicable to the Offer.

The Fund has filed an Issuer Tender Offer Statement on Schedule TO with the Securities and Exchange Commission (the "SEC"), which includes certain information relating to the Offer summarized herein. A free copy of such statement may be obtained from the Fund at www.bdebt.com, by contacting the Transfer Agent at (888) 204-3956, or from the SEC's internet web site, http://www.sec.gov.

#### FINANCIAL STATEMENTS
The audited financial statements of the Fund for the period ended December 31, 2025, as filed with the SEC on EDGAR on Form 10-K on March 2, 2026, are incorporated by reference. The Fund will prepare and transmit to Shareholders the audited financial statements of the Fund within 90 days after the close of the period for which the report is being made, or as otherwise required by the 1940 Act.

10<br>

## Ex-99.A1Iii

#### Exhibit (a)(1)(iii)

#### LETTER OF TRANSMITTAL <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### REGARDING <br>

#### SHARES OF BENEFICIAL INTEREST <br>

#### IN <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### BLACKROCK PRIVATE CREDIT FUND <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### TENDERED PURSUANT TO THE OFFER TO PURCHASE <br>

#### DATED MAY 11, 2026

#### The Offer will expire <br>

#### at, and this Letter of Transmittal must be <br>

#### received by, 11:59 p.m., Eastern Time, <br>

#### on June 8, 2026, unless the Offer is extended.
**If you do not want to sell your Shares at this time, please disregard this notice. This is simply notification of the Fund's tender offer. If you decide to tender, you are responsible for confirming that your financial adviser or the** 

#### Fund's Transfer Agent has received your documents in good order.

------

Ladies and Gentlemen:

The undersigned hereby tenders to BlackRock Private Credit Fund, a non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the "1940 Act") and is organized as a Delaware statutory trust (the "Fund"), the shares of beneficial interest ("Shares") in the Fund or portion thereof held by the undersigned, described and specified below, on the terms and conditions set forth in the offer to purchase dated May 11, 2026 ("Offer to Purchase"), receipt of which is hereby acknowledged, and in this Letter of Transmittal (which together constitute the "Offer"). **The offer and this Letter of Transmittal are subject to all the terms and conditions set forth in the Offer to Purchase, including, but not limited to, the absolute right of the Fund to reject any and all tenders determined by it, in its sole discretion, not to be received timely and in the appropriate form.**

The undersigned hereby sells to the Fund the Shares of the Fund tendered hereby pursuant to the Offer. The undersigned hereby represents and warrants that the undersigned has full power and authority to tender, sell, assign and transfer Shares tendered hereby and all dividends, distributions (including, without limitation, distributions of additional Shares) and rights declared, paid or distributed in respect of such Shares that are declared, paid or distributed in respect of a record date occurring on or after the date on which the Shares are accepted for repurchase by the Fund (collectively, "Distributions"), that when such Shares are accepted for repurchase by the Fund, the Fund will acquire good, marketable and unencumbered title thereto and to all Distributions, free and clear of all liens, restrictions, charges and encumbrances, and that none of such Shares and Distributions will be subject to any adverse claim. The undersigned, upon request, shall execute and deliver all additional documents deemed by the Transfer Agent or the Fund to be necessary or desirable to complete the sale, assignment and transfer of Shares tendered hereby and all Distributions.

The undersigned recognizes that under certain circumstances set forth in the Offer, the Fund may not be required to purchase any of the Shares of the Fund or portion thereof tendered hereby. The undersigned recognizes that, if the Offer is oversubscribed, not all the undersigned's Shares of the Fund may be repurchased.

A non-transferable, non-interest bearing promissory note (a "Repurchase Instrument") for the purchase price will be issued to the undersigned if the Fund accepts for purchase the Shares tendered hereby. The undersigned acknowledges that the Repurchase Instrument will be held for the undersigned by State Street Bank and Trust Company, the Fund's transfer agent. The cash payment of the purchase price for the Shares tendered by the undersigned and accepted for purchase by the Fund will be made by wire transfer of the proceeds to the undersigned's account at the financial intermediary from which the undersigned's subscription funds were debited, or, for direct investments without a financial intermediary, to the account designated by the undersigned in the Tender Offer transmittal letter.

If the undersigned's Shares are tendered and accepted for purchase, the Repurchase Instrument will provide for payment of the purchase price in one installment as described in Section 6 "Purchases and Payment" of the Offer to Purchase. The undersigned recognizes that the amount of the purchase price for Shares will be based on the unaudited net asset value of the Shares as of June 30, 2026 (the "Valuation Date").

Upon becoming bound by the terms of a Repurchase Instrument, the undersigned shall retain, with respect to the repurchased Shares, all rights to inspect the books and records of the Fund and to receive financial and other reports relating to the Fund until the payment is made for such repurchased Shares. Except as otherwise provided in the Repurchase Instrument, the undersigned shall not be a shareholder of the Fund, with respect to such repurchased Shares, and shall have no other rights (including, without limitation, any voting rights) under the Fund's Fourth Amended and Restated Agreement and Declaration of Trust, as amended, with respect to such repurchased Shares, from and after the date of acceptance of their Shares for repurchase by the Fund.

All authority herein conferred or agreed to be conferred shall survive the death or incapacity of the undersigned and the obligation of the undersigned hereunder shall be binding on the heirs, personal representatives, successors and assigns of the undersigned. Except as stated in Section 5 "Withdrawal Rights" of the Offer to Purchase, this tender is irrevocable.

(PAGE 1 of 4)

------

#### VALUATION DATE : June 30, 2026

#### TENDER OFFER EXPIRATION DATE : 11:59 p.m. (Eastern Time), June 8, 2026

#### PARTS 1, 2, 3, AND 4 MUST BE COMPLETED AND IN GOOD ORDER IN ORDER TO PROCESS YOUR REQUEST
A. **IF YOU INVEST IN THE FUND <u>THROUGH A FINANCIAL INTERMEDIARY</u>: PLEASE SEND COMPLETED FORMS TO YOUR FINANCIAL ADVISOR / PORTFOLIO MANAGER** 

**If You Invest In The Fund Through A Financial Intermediary Through Whom You Expect To Have Your Tender Offer Request Submitted, Please Allow For Additional Processing Time As The <u>Letter of</u> <u>Transmittal Must Ultimately Be Received By The Fund's Transfer Agent No Later Than 11:59 p.m.</u> <u>(Eastern Time) On The Expiration Date</u>.** 

#### OR
B. **IF YOU INVEST IN THE FUND <u>DIRECTLY (NOT THROUGH A FINANCIAL INTERMEDIARY)</u>: PLEASE MAIL TO THE FUND'S TRANSFER AGENT AT:** 

---

| | |
|:---|:---|
| FOR FIRST CLASS MAIL:<br>State Street Bank and Trust Company<br>Attn: BlackRock Alternative Funds<br>P.O. Box 5493 <br>Boston, MA 02206 | E-MAIL: BLK_RegAlts_INQ@statestreet.com<br>FOR ADDITIONAL INFORMATION<br>CALL: 1-888-204-3956  |
| *FOR OVERNIGHT MAIL:*<br>*State Street Bank and Trust Company*<br>*Attn: BlackRock Alternative Funds*<br>*1776 Heritage Drive*<br>*JAB/3*<br>*North Quincy, MA 02171* |  |

---

\* \* \*

#### PART 1 – NAME (AS IT APPEARS ON YOUR BLACKROCK PRIVATE CREDIT FUND STATEMENT) AND CONTACT INFORMATION

---

| |
|:---|
| Fund Account #:  |
| Account Name/Registration:  |
| Address:  |
| City, State, Zip  |
| Telephone Number:  |
| Email Address:  |
| Financial Intermediary Firm Name:  |
| Financial Intermediary Account #:  |
| Financial Advisor Name:  |
| Financial Advisor Telephone #: |

---

(PAGE 2 of 4)

------

#### PART 2 – REQUESTED TENDER AMOUNT

#### Please select repurchase type by checking one of the boxes below. If you are requesting a partial repurchase, please provide a number of Shares.

---

| | | |
|:---|:---|:---|
| ☐ | Full Repurchase  | Full Repurchase  |
| ☐ | Partial Repurchase\* of<u> </u> Class S Shares (please only provide a number of Shares, not a dollar amount)  | Partial Repurchase\* of<u> </u> Class S Shares (please only provide a number of Shares, not a dollar amount)  |
| ☐ | Partial Repurchase\* of<u> </u> Class D Shares (please only provide a number of Shares, not a dollar amount)  | Partial Repurchase\* of<u> </u> Class D Shares (please only provide a number of Shares, not a dollar amount)  |
| ☐ | Partial Repurchase\* of<u> </u> Institutional Shares (please only provide a number of Shares, not a dollar amount)  | Partial Repurchase\* of<u> </u> Institutional Shares (please only provide a number of Shares, not a dollar amount)  |
| \* | If the requested partial repurchase would put the account balance below the required minimum balance, the Fund may reduce the amount to be repurchased such that the required minimum balance is maintained, unless you indicate otherwise by checking the following box:  | If the requested partial repurchase would put the account balance below the required minimum balance, the Fund may reduce the amount to be repurchased such that the required minimum balance is maintained, unless you indicate otherwise by checking the following box:  |
|  | ☐ | Change request to Full Repurchase if amount requested to be repurchased would need to be reduced to maintain minimum account balance. |

---

---

| | |
|:---|:---|
| **BLACKROCK PRIVATE CREDIT FUND ACCOUNT #:** |  |
|  | **(Should be the same as on page 2)** |

---

#### PART 3 – PAYMENT
<u>For investors with a financial intermediary</u>: Payments will be directed back to the account from which your subscription funds were debited. Contact your financial intermediary or account manager if you have any questions.

<u>For direct investors</u>: Payments will be directed to the account designated by the undersigned for receipt of wires for the distribution of dividends and capital gains. Complete the wire instructions attached hereto and provide directly to the Fund's Transfer Agent.

(PAGE 3 of 4)

------

#### PART 4 – SIGNATURE(S)
The undersigned acknowledges that this request is subject to all the terms and conditions set forth in the Fund's Prospectus and the Offer to Purchase dated May 11, 2026 (the "Offer to Purchase"). This request is irrevocable except as described in the Offer to Purchase. The undersigned represents that the undersigned is the beneficial owner of the shares in the Fund to which this repurchase request relates, or that the person signing this request is an authorized representative of the tendering shareholder.

In the case of joint accounts, each joint holder must sign this Letter of Transmittal. If this Letter of Transmittal is signed by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing, and proper evidence satisfactory to the Fund of their authority so to act must be submitted together with this Letter of Transmittal.

---

| | | |
|:---|:---|:---|
| Signature | Print Name of Authorized Signatory (and Title if applicable) | Date  |
| Signature | Print Name of Authorized Signatory (and Title if applicable) | Date |

---

#### Wire Instructions (To be Completed Only by Direct Investors)
Tender Offer proceeds should be delivered to the following account (must be in the name of the investor):

---

| |
|:---|
| To:  |
| Correspondent bank name (if applicable):  |
| Correspondent bank routing #/SWIFT:  |
| Beneficiary bank name:  |
| Beneficiary bank SWIFT/Account #:  |
| In favor of:  |
| Account #: |

---

(PAGE 4 of 4)

------

#### FOR USE BY CLIENTS OF MERRILL LYNCH, PIERCE, FENNER & SMITH, INC.

---

| | |
|:---|:---|
| **Tender Offer** | Signature Pages — U.S. Investors |

---

<br> Document No.: Client Account No.: <br>

These Tender Offer Request Signature Pages (or "Signature Pages") relate to the client's (the "Client") redemption or repurchase request from one or more investment funds (each, a "Fund"). The term "Fund" or "Funds" as used herein refers to each investment fund from which the Client is redeeming as set forth in the Signature Pages. The term "Interest" refers to any unit of participation, share, or other form of interest issued by a Fund.

#### Registration / Client Account Details

---

| | | |
|:---|:---|:---|
| Account registration and address  | Account registration and address  | Account registration and address  |
| Account classification | Taxpayer identification number | Account Number  |
| Exempt payee code  | Exempt payee code  | Exempt payee code  |
| Exemption from FATCA reporting code  | Exemption from FATCA reporting code  | Exemption from FATCA reporting code  |
| FATCA classifications | FATCA classifications | FATCA classifications |

---

<br> Document No.: 1 of 4 Client Account No.: <br>                  

------

#### Request Tender / Redemption Details

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Fund Name:  | Fund Name:  | Fund Name:  | Fund Name:  | Fund Name:  | Fund Name:  |
| Effective Date | Cut-off Date | Channel | Tender Type | Tender Type | Units (If Partial)  |
| Effective Date | Cut-off Date | Channel | ☐ Full | ☐ Partial | Units (If Partial)  |

---

#### Payment
Cash payments due pursuant to this request will be made directly to Merrill Lynch, Pierce, Fenner & Smith, Inc. or Private Bank, as indicated above, who will facilitate the distribution of proceeds into the Client's account.

#### Signature
By executing and submitting these Signature Pages, you acknowledge that this request is subject to all of the terms and conditions set forth in the Offer and the Letter of Transmittal. Except as stated in the Offer, this request is irrevocable. You acknowledge the absolute right of the Fund to reject any and all tenders, including those that the Fund determines, in its sole discretion, are not in the appropriate form. You represent that you are the beneficial owner of the Interests in the Fund to which this request relates, or that the person signing this request is an authorized representative of the redeeming investor.

<br> Document No.: 2 of 4 Client Account No.: <br>                  

------

---

| | |
|:---|:---|
| **Internal Revenue Code Certification**  | **Internal Revenue Code Certification**  |
| Under penalties of perjury, by signature below, you hereby represent, warrant and certify as follows: (a) the Social Security/ Taxpayer ID Number set forth in these Signature Pages is your true, correct and complete Social Security/Taxpayer ID Number, and you are a U.S. citizen or other United States person (as defined in the instructions to IRS Form W-9); (b) you are not subject to backup withholding because (i) you are exempt from backup withholding, (ii) you have not been notified by the Internal Revenue Service that you are subject to backup withholding as a result of a failure to report all interest or dividends, or (iii) the Internal Revenue Service has notified you that you are no longer subject to backup withholding; and (c) if an exemption from the Foreign Account Tax Compliance Act (FATCA) reporting was on this document then you certify that the FATCA code(s) entered on this document, if any, indicating that you are exempt from FATCA reporting is correct.  | Under penalties of perjury, by signature below, you hereby represent, warrant and certify as follows: (a) the Social Security/ Taxpayer ID Number set forth in these Signature Pages is your true, correct and complete Social Security/Taxpayer ID Number, and you are a U.S. citizen or other United States person (as defined in the instructions to IRS Form W-9); (b) you are not subject to backup withholding because (i) you are exempt from backup withholding, (ii) you have not been notified by the Internal Revenue Service that you are subject to backup withholding as a result of a failure to report all interest or dividends, or (iii) the Internal Revenue Service has notified you that you are no longer subject to backup withholding; and (c) if an exemption from the Foreign Account Tax Compliance Act (FATCA) reporting was on this document then you certify that the FATCA code(s) entered on this document, if any, indicating that you are exempt from FATCA reporting is correct.  |
| **Certification instructions.**  | **Certification instructions.**  |
| ☐ | Check this box if you have been notified by the IRS that you are currently subject to backup withholding because you have failed to report all interest and dividends on your tax return. **The Internal Revenue Service does not require your consent to any provision of this document other than the certifications required to avoid backup withholding.** |

---

*If one or more of the signatories listed here does not need to sign on behalf of the account, cross out their name. This does not apply to joint accounts.* 

---

| | |
|:---|:---|
| **Signature 1:** | **Signature 1:** |
| Signature 1 | Date  |
| Signer's name<br>(please print) | Title  |
| **Signature 2:** |  |
| Signature 2 | Date  |
| Signer's name<br>*(please print)* | Title  |
| **Signature 3:** |  |
| Signature 3 | Date  |
| Signer's name<br>*(please print)* | Title  |
| **Signature 4:** |  |
| Signature 4 | Date  |
| Signer's name<br>*(please print)* | Title |

---

<br> Document No.: 3 of 4 Client Account No.: <br>                  

------

---

| | |
|:---|:---|
| **Signature 5:** | **Signature 5:** |
| Signature 5 | Date  |
| Signer's name<br>*(please print)* | Title  |
| **Signature 6:** | **Signature 6:** |
| Signature 6 | Date  |
| Signer's name<br>*(please print)* | Title |

---

#### Investment Professional Attestation
The undersigned Investment Professional hereby certifies that the Client is known to and is a Client of the Investment Professional, and the Investment Professional has had substantive discussions with the Client regarding the Client's investment objectives. The Investment Professional confirms that he/she has a reasonable basis for believing (i) that all of the representations made by the Client on these Signature Pages are true and correct, (ii) based on information obtained from the Client concerning the Client's investment objectives, other investments, financial situation and needs, and any other information known to the Investment Professional, that a tender, redemption or withdrawal from the Fund is suitable for the Client, and (iii) that the Client's contact information on record with the selling agent and as noted on these Signature Pages is true and correct. The Investment Professional confirmed that the Client is aware of the financial terms and risks applicable to a tender, redemption or withdrawal from the Fund and the specific class(es)/tranche(s) and series of Interests issued by each Fund in which the Client currently invests.

---

| | |
|:---|:---|
| Investment Professional name | Production number / PB CAI number  |
| Investment Professional signature | Date |

---

<br> Document No.: 4 of 4 Client Account No.: <br>                  

------

#### LETTER OF TRANSMITTAL <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### REGARDING <br>

#### SHARES OF BENEFICIAL INTEREST <br>

#### IN <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### BLACKROCK PRIVATE CREDIT FUND <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### TENDERED PURSUANT TO THE OFFER TO PURCHASE <br>

#### DATED MAY 11, 2026

#### The Offer will expire <br>

#### at, and this Letter of Transmittal must be <br>

#### received by, 11:59 p.m., Eastern Time, <br>

#### on June 8, 2026, unless the Offer is extended.

#### If you do not want to sell your Shares at this time, please disregard this notice. This is simply <br>

#### notification of the Fund's tender offer. If you decide to tender, you are responsible for confirming <br>

#### that the Fund's Transfer Agent has received your documents in good order.

------

Ladies and Gentlemen:

The undersigned hereby tenders to BlackRock Private Credit Fund, a non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the "1940 Act") and is organized as a Delaware statutory trust (the "Fund"), the shares of beneficial interest ("Shares") in the Fund or portion thereof held by the undersigned, described and specified below, on the terms and conditions set forth in the offer to purchase dated May 11, 2026 ("Offer to Purchase"), receipt of which is hereby acknowledged, and in this Letter of Transmittal (which together constitute the "Offer"). **The offer and this Letter of Transmittal are subject to all the terms and conditions set forth in the Offer to Purchase, including, but not limited to, the absolute right of the Fund to reject any and all tenders determined by it, in its sole discretion, not to be received timely and in the appropriate form.**

The undersigned hereby sells to the Fund the Shares of the Fund tendered hereby pursuant to the Offer. The undersigned hereby represents and warrants that the undersigned has full power and authority to tender, sell, assign and transfer Shares tendered hereby and all dividends, distributions (including, without limitation, distributions of additional Shares) and rights declared, paid or distributed in respect of such Shares that are declared, paid or distributed in respect of a record date occurring on or after the date on which the Shares are accepted for repurchase by the Fund (collectively, "Distributions"), that when such Shares are accepted for repurchase by the Fund, the Fund will acquire good, marketable and unencumbered title thereto and to all Distributions, free and clear of all liens, restrictions, charges and encumbrances, and that none of such Shares and Distributions will be subject to any adverse claim. The undersigned, upon request, shall execute and deliver all additional documents deemed by the Transfer Agent or the Fund to be necessary or desirable to complete the sale, assignment and transfer of Shares tendered hereby and all Distributions.

The undersigned recognizes that under certain circumstances set forth in the Offer, the Fund may not be required to purchase any of the Shares of the Fund or portion thereof tendered hereby. The undersigned recognizes that, if the Offer is oversubscribed, not all the undersigned's Shares of the Fund may be repurchased.

A non-transferable, non-interest bearing promissory note (a "Repurchase Instrument") for the purchase price will be issued to the undersigned if the Fund accepts for purchase the Shares tendered hereby. The undersigned acknowledges that the Repurchase Instrument will be held for the undersigned by State Street Bank and Trust Company, the Fund's transfer agent. The cash payment of the purchase price for the Shares tendered by the undersigned and accepted for purchase by the Fund will be made by wire transfer of the proceeds to the undersigned's account at the financial intermediary from which the undersigned's subscription funds were debited, or, for direct investments without a financial intermediary, to the account designated by the undersigned in the Tender Offer transmittal letter.

If the undersigned's Shares are tendered and accepted for purchase, the Repurchase Instrument will provide for payment of the purchase price in one installment as described in Section 6 "Purchases and Payment" of the Offer to Purchase. The undersigned recognizes that the amount of the purchase price for Shares will be based on the unaudited net asset value of the Shares as of June 30, 2026 (the "Valuation Date").

Upon becoming bound by the terms of a Repurchase Instrument, the undersigned shall retain, with respect to the repurchased Shares, all rights to inspect the books and records of the Fund and to receive financial and other reports relating to the Fund until the payment is made for such repurchased Shares. Except as otherwise provided in the Repurchase Instrument, the undersigned shall not be a shareholder of the Fund, with respect to such repurchased Shares, and shall have no other rights (including, without limitation, any voting rights) under the Fund's Fourth Amended and Restated Agreement and Declaration of Trust, as amended, with respect to such repurchased Shares, from and after the date of acceptance of their Shares for repurchase by the Fund.

All authority herein conferred or agreed to be conferred shall survive the death or incapacity of the undersigned and the obligation of the undersigned hereunder shall be binding on the heirs, personal representatives, successors and assigns of the undersigned. Except as stated in Section 5 "Withdrawal Rights" of the Offer to Purchase, this tender is irrevocable.

<br> Document No.: 1 of 4 Client Account No.: <br>                  

------

#### VALUATION DATE : June 30, 2026

#### TENDER OFFER EXPIRATION DATE : 11:59 p.m. (Eastern Time), June 8, 2026

#### PARTS 1, 2, 3, AND 4 MUST BE COMPLETED AND IN GOOD ORDER IN ORDER TO PROCESS YOUR REQUEST

#### PLEASE DELIVER TO THE TRUST'S TRANSFER AGENT AT:

---

| | |
|:---|:---|
| *FOR FIRST CLASS MAIL:*<br>*State Street Bank and Trust Company*<br>*Attn: BlackRock Alternative Funds*<br>*P.O. Box 5493* <br>*Boston, MA 02206* | E-MAIL: BLK_RegAlts_INQ@statestreet.com<br>FOR ADDITIONAL INFORMATION<br>CALL: 1-888-204-3956  |
| *FOR OVERNIGHT MAIL:*<br>*State Street Bank and Trust Company*<br>*Attn: BlackRock Alternative Funds*<br>*1776 Heritage Drive*<br>*JAB/3*<br>*North Quincy, MA 02171* |  |

---

\* \* \*

#### PART 1 – NAME (AS IT APPEARS ON YOUR BLACKROCK PRIVATE CREDIT FUND STATEMENT) AND CONTACT INFORMATION

---

| |
|:---|
| Fund Account #: |
| Account Name/Registration: |
| Address: |
| City, State, Zip |
| Telephone Number: |
| Email Address: |
| Financial Intermediary Firm Name: |
| Financial Intermediary Account #: |
| Financial Advisor Name: |
| Financial Advisor Telephone #: |

---

<br> Document No.: 2 of 4 Client Account No.: <br>                  

------

#### PART 2 – REQUESTED TENDER AMOUNT

#### Please select repurchase type by checking one of the boxes below. If you are requesting a partial repurchase, please provide a number of Shares.

---

| | | |
|:---|:---|:---|
| ☐ | Full Repurchase  | Full Repurchase  |
| ☐ | Partial Repurchase\* of<u> </u> Class S Shares (please only provide a number of Shares, not a dollar amount)  | Partial Repurchase\* of<u> </u> Class S Shares (please only provide a number of Shares, not a dollar amount)  |
| ☐ | Partial Repurchase\* of<u> </u> Class D Shares (please only provide a number of Shares, not a dollar amount)  | Partial Repurchase\* of<u> </u> Class D Shares (please only provide a number of Shares, not a dollar amount)  |
| ☐ | Partial Repurchase\* of<u> </u> Institutional Shares (please only provide a number of Shares, not a dollar amount)  | Partial Repurchase\* of<u> </u> Institutional Shares (please only provide a number of Shares, not a dollar amount)  |
| \* | If the requested partial repurchase would put the account balance below the required minimum balance, the Fund may reduce the amount to be repurchased such that the required minimum balance is maintained, unless you indicate otherwise by checking the following box:  | If the requested partial repurchase would put the account balance below the required minimum balance, the Fund may reduce the amount to be repurchased such that the required minimum balance is maintained, unless you indicate otherwise by checking the following box:  |
|  | ☐ | Change request to Full Repurchase if amount requested to be repurchased would need to be reduced to maintain minimum account balance. |

---

---

| | |
|:---|:---|
| **BLACKROCK PRIVATE CREDIT FUND ACCOUNT #:**  |  |
|  | **(Should be the same as on page 2)** |

---

#### PART 3 – PAYMENT
Payments will be directed to the account designated by the undersigned for receipt of wires for the distribution of dividends and capital gains. Complete the wire instructions attached hereto and provide directly to the Fund's Transfer Agent.

------

<br> Document No.: 3 of 4 Client Account No.: <br>                  

------

#### PART 4 – SIGNATURE(S)
The undersigned acknowledges that this request is subject to all the terms and conditions set forth in the Fund's Prospectus and the Offer to Purchase dated May 11, 2026 (the "Offer to Purchase"). This request is irrevocable except as described in the Offer to Purchase. The undersigned represents that the undersigned is the beneficial owner of the shares in the Fund to which this repurchase request relates, or that the person signing this request is an authorized representative of the tendering shareholder.

In the case of joint accounts, each joint holder must sign this Letter of Transmittal. If this Letter of Transmittal is signed by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing, and proper evidence satisfactory to the Fund of their authority so to act must be submitted together with this Letter of Transmittal.

---

| | | |
|:---|:---|:---|
| Signature | Print Name of Authorized Signatory (and Title if applicable) | Date  |
| Signature | Print Name of Authorized Signatory (and Title if applicable) | Date |

---

#### Wire Instructions (To be Completed Only by Direct Investors)
Tender Offer proceeds should be delivered to the following account (must be in the name of the investor):

---

| |
|:---|
| To:  |
| Correspondent bank name (if applicable):  |
| Correspondent bank routing #/SWIFT:  |
| Beneficiary bank name:  |
| Beneficiary bank SWIFT/Account #:  |
| In favor of:  |
| Account #: |

---

<br> Document No.: 4 of 4 Client Account No.: <br>

## Ex-99.A1Iv

#### Exhibit (a)(1)(iv)
BLACKROCK PRIVATE CREDIT FUND <br>

c/o State Street Bank and Trust Company <br>

Attn: BlackRock Alternative Funds <br>

1776 Heritage Drive <br>

JAB/3 <br>

North Quincy, MA 02171

#### THIS LETTER IS BEING SENT TO YOU BECAUSE YOU TENDERED COMMON SHARES OF BENEFICIAL INTEREST IN THE FUND, OR A PORTION THEREOF.
[DATE]

Dear Shareholder:

This letter serves to inform you that BlackRock Private Credit Fund (the "Fund") has received and accepted for repurchase (subject to any proration in the event the tender offer was oversubscribed) your tender of common shares of beneficial interest ("Shares") in the Fund.

In accordance with the terms of the tender offer, you will be issued a non-interest bearing, non-transferrable promissory note (the "Note"), which will be held on your behalf by State Street Bank and Trust Company, the Fund's transfer agent ("Transfer Agent"), entitling you to receive payment for your tendered and repurchased Shares (subject to any proration in the event the tender offer was oversubscribed) in an amount equal to the net asset value of such Shares as of June 30, 2026 less the 2% Early Repurchase Deduction (if applicable).

If you have any questions (or wish to request a copy of your Note), please contact the Fund's Transfer Agent at (888) 204-3956. Investors who invested in the Fund through a financial intermediary should contact their financial intermediary directly.

---

| |
|:---|
| Sincerely,  |
| BlackRock Private Credit Fund |

---

## Ex-99.A1V

#### Exhibit (a)(1)(v)

#### FORM OF <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### NON-NEGOTIABLE PROMISSORY NOTE <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### BLACKROCK PRIVATE CREDIT FUND
Dated: [insert date]

FOR VALUE RECEIVED, BlackRock Private Credit Fund ("Payor" or the "Fund"), a Delaware statutory trust issuing its common shares of beneficial interest ("Shares"), hereby promises individually to each of the payees set forth on Exhibit A hereto (each, a "Payee") to pay the Payment Amount (as defined in Section 2) in a single installment as discussed below, payable with respect to that Payee. This Note shall be deemed a separate instrument issued individually with respect to each Payee.

This Note is being issued so that Payor may repurchase Shares (the "Repurchased Shares") from the Payees pursuant to the terms and subject to the conditions set out in the Offer to Purchase dated May 11, 2026 and the Letter of Transmittal submitted by each Payee (in the case of Payees that hold their account directly with BlackRock) (which Offer to Repurchase and Letter of Transmittal, together with any amendments or supplements thereto, collectively constitute the "Offer"). This Note is not negotiable and is not interest-bearing.

1. <u>General Payment Provisions</u>. The Payor will make the Payment Amount under this Note in a single installment as described in Section 2 below in such currency of the United States of America as will be legal tender at the time of payment. Payment under this Note will be made by immediately available funds to Payee's account, either directly or at Payee's authorized agent as previously identified to Payor by Payee. 

2. <u>Payment</u>. The "Payment Amount" for each Payee will be an amount equal to the net asset value of the Repurchased Shares determined as of June 30, 2026 (the "Valuation Date") (as determined in accordance with the Fund's then-current prospectus (the "Prospectus")) reduced by the Early Repurchase Deduction (as defined herein), if applicable. Unless the existence of changes in tax or other laws or regulations or unusual market conditions result in a delay, the Payor will make payment under this Note on or before 30 days after the Valuation Date. 

Repurchased Shares that are purchased in a tender offer with a Valuation Date that is within the 12 month period following the date of the closing at which the Payee subscribed for such Shares are subject to an "early repurchase deduction" (the "Early Repurchase Deduction") at a rate of 2% of the aggregate net asset value of such Shares.

3.<br> <u>Optional Prepayment</u>. This Note may be prepaid, without premium, penalty or notice, at any time on or after the Valuation Date.

4.<br> <u>Events of Default</u>.

(a) The occurrence of any of the following events shall be deemed to be an "Event of Default" under this Note; *provided, however*, that an event of default with respect to one Payee shall not in and of itself cause an event of default with respect to any other Payee: 

(i)<br> The Payor defaults in payment when due to the applicable Payee and any such default continues for a period of ten (10) days; or

(ii) (1) The Payor shall commence any proceeding or other action relating to Payor in bankruptcy or seeking reorganization, arrangement, readjustment, dissolution, liquidation, winding-up, relief or composition of the Payor or the debts of the Payor under any law relating to bankruptcy, insolvency or reorganization or relief of debtors; (2) the Payor applies for, or consents or acquiesces to, the appointment of a receiver, conservator, trustee or similar officer for the Payor or for all or substantially all of the property of the Payor; (3) the Payor makes a general assignment for the benefit of creditors of the Payor; or (4) the Payor generally admits its inability to pay its debts as they become due and payable; or 

(iii) (1) The commencement of any proceeding or the taking of any other action against Payor in bankruptcy or seeking reorganization, arrangement, readjustment, dissolution, liquidation, winding-up, relief or composition of the Payor or the debts of the Payor under any law relating to bankruptcy, insolvency or reorganization or relief of debtors and the continuance of any of 

------

such events for sixty (60) days undismissed, unbonded or undischarged; or (2) the appointment of a receiver, conservator, trustee or similar officer for the Payor or for all or substantially all of the property of the Payor and the continuance of any such event for sixty (60) days undismissed, unbonded or undischarged.

(b) Upon the occurrence of an Event of Default, the entire unpaid amount of this Note outstanding shall become immediately due and payable, without presentment, demand, protest, or other notice of any kind, all of which are expressly waived, and without any action on the part of the Payee. 

5. <u>Inspection of Books and Records; Reports</u>. Each Payee will continue to be a Shareholder of the Fund with respect to the Repurchased Shares until the Valuation Date and may exercise his or her voting rights with respect to the Repurchased Shares until the Valuation Date. Following the Valuation Date, a Payee shall retain, with respect to such Repurchased Shares, all rights to inspect the books and records of the Fund and to receive financial and other reports relating to the Fund until the payment of the Payment Amount in respect of such Payee has been made in full, but shall have no other rights of a Shareholder in respect of the Repurchased Shares (including, without limitation, any voting rights) under the Fund's Agreement and Declaration of Trust. 

6.<br> <u>Miscellaneous</u>.

(a) <u>Governing Law; Consent to Jurisdiction</u>. This Note and the rights and remedies of the Payor and each Payee will be governed by and construed in accordance with the laws of the State of New York applicable to agreements made and to be wholly performed within such State, without regard to the conflict of laws principles of such State. Any legal action, suit or proceeding arising out of or relating to this Note may be instituted in any state or federal court located within the County of New York, State of New York, and each party hereto agrees not to assert, by way of motion, as a defense, or otherwise, in any such action, suit or proceeding, any claim that it is not subject personally to the jurisdiction of such court, that the venue of the action, suit or proceeding is improper or that this Note or the subject matter hereof may not be enforced in or by such court. 

(b) <u>Notices</u>. All communications under this Note will be given in writing, sent by registered mail, to the address set forth below in the case of the Payor, or to the address of the Payee set forth on Exhibit A hereto in the case of a Payee, or to such other address as such party will have specified in writing to the other party hereto, and will be deemed to have been delivered effective at the earlier of its receipt or within two (2) days after dispatch. 

<br> <u>Payor Address</u>: BlackRock Private Credit Fund<br>50 Hudson Yards<br>New York, NY 10001<br>Telephone: (212) 810-5800<br>Attention: John M. Perlowski <br>

(c) <u>Severability, Binding Effect</u>. Any provision of this Note that is prohibited or unenforceable in any jurisdiction will, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction will not invalidate or render unenforceable such provision in any other jurisdiction. 

(d)<br> <u>Amendment; Waiver</u>. No provision of this Note may be waived, altered or amended with respect to any Payee, except by written agreement between the Payor and such Payee.

(e)<br> <u>Waiver of Presentment</u>. Payor hereby waives presentment, protest, demand for payment and notice of default or nonpayment to or upon Payor with respect to this Note.

(f)<br> <u>Entire Agreement</u>. This Note and the Offer set out the entire agreement between the parties and supersede any prior oral or written agreement between the parties.

(g) <u>Separate Obligations</u>. The obligations of the Payor to each Payee hereunder are separate rather than joint, and a Payee may seek payment or the enforcement of any obligation of the Payor under this Note only with respect to itself and not any other Payee hereunder. 

------

(h) <u>Delaware Statutory Trust</u>. The obligations of the Fund hereunder are not binding upon any trustee or shareholder of the Fund personally, but bind only the Fund and the Fund's property. A copy of the Fourth Amended and Restated Agreement and Declaration of Trust of the Fund is on file with the State of Delaware, and notice is hereby given that this instrument is executed on behalf of the trustees of the Fund as trustees and not individually and that the obligations of or arising out of this instrument are not binding on any of the trustees, officers or shareholders individually, but are binding only upon the trust property of the Fund. 

[Signature Page Follows]

------

IN WITNESS WHEREOF, Payor has duly caused this Note to be duly executed as of the date first above written.

---

| | |
|:---|:---|
| BLACKROCK PRIVATE CREDIT FUND  | BLACKROCK PRIVATE CREDIT FUND  |
| By: |  |
|  | Name:  |
|  | Title: |

---

## Ex-99.A1Vi

#### Exhibit (a)(1)(vi)

#### NOTICE OF WITHDRAWAL OF TENDER <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### Regarding Common Shares of Beneficial Interest In <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### BlackRock Private Credit Fund <br>

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

#### Tendered Pursuant to the Offer to Purchase <br>

#### Dated May 11, 2026
**The Offer will expire** <br>

**at, and this Notice of Withdrawal must be** <br>

**received by, 11:59 p.m., Eastern Time,** <br>

**on June 8, 2026, unless the Offer is extended.**

A. **IF YOU SUBMITTED YOUR TENDER OFFER <u>THROUGH A FINANCIAL INTERMEDIARY</u>: COMPLETE THIS NOTICE OF WITHDRAWAL AND RETURN TO YOUR FINANCIAL ADVISOR / PORTFOLIO MANAGER** 

*You are responsible for confirming that this Notice of Withdrawal is received by your Financial Advisor or Portfolio Manager. If you fail to confirm receipt of this Notice, there can be no assurance that your withdrawal will be honored by the Fund.* 

#### OR
B. **IF YOU SUBMITTED YOUR TENDER OFFER <u>DIRECTLY TO THE FUND'S TRANSFER AGENT</u>: PLEASE COMPLETE THIS NOTICE OF WITHDRAWAL AND RETURN TO THE FUND'S TRANSFER AGENT AT:** 

---

| | |
|:---|:---|
| *FOR FIRST CLASS MAIL:*<br>*State Street Bank and Trust Company* <br>*Attn: BlackRock Alternative Funds*<br>*P.O. Box 5493* <br>*Boston, MA 02206* | E-MAIL: BLK_RegAlts_INQ@statestreet.com<br>FOR ADDITIONAL INFORMATION<br>CALL: 1-888-204-3956  |
| *FOR OVERNIGHT MAIL:*<br>*State Street Bank and Trust Company*<br>*Attn: BlackRock Alternative Funds*<br>*1776 Heritage Drive*<br>*JAB/3*<br>*North Quincy, MA 02171* |  |

---

*You are responsible for confirming that this Notice of Withdrawal is received by State Street Bank and Trust Company, the Fund's Transfer Agent. To assure good delivery, please send this Notice to the Transfer Agent, and not to your financial advisor. If you fail to confirm receipt of this Notice, there can be no assurance that your withdrawal will be honored by the Fund.*

(PAGE 1 of 2)

------

Ladies and Gentlemen:

The undersigned hereby withdraws the tender of its common shares of beneficial interest ("Shares") in **BlackRock Private Credit Fund** (the "Fund") for purchase by the Fund that previously was submitted by the undersigned in a Letter of Transmittal dated<u> </u>.

This tender was in the amount of:

☐<br> All Shares

☐<br> Portion of Class S Shares expressed as number of units:<u> </u>

☐<br> Portion of Class D Shares expressed as number of units:<u> </u>

☐<br> Portion of Institutional Shares expressed as number of units:<u> </u>

---

| |
|:---|
| Fund Account #: |
| Account Name/Registration: |
| Address: |
| City, State, Zip |
| Telephone Number: |
| Email Address: |
| Financial Intermediary Firm Name: |
| Financial Intermediary Account #: |
| Financial Advisor Name: |
| Financial Advisor Telephone #: |

---

The undersigned recognizes that upon submission on a timely basis of this Notice of Withdrawal of Tender, properly executed, the Shares previously tendered will not be purchased by the Fund.

The undersigned represents that the undersigned is the beneficial owner of the shares in the Fund to which this Notice of Withdrawal of Tender relates, or that the person signing this request is an authorized representative of the withdrawing shareholder.

In the case of joint accounts, each joint holder must sign this Notice of Withdrawal of Tender. If this Notice of Withdrawal of Tender is signed by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing, and proper evidence satisfactory to the Fund of their authority so to act must be submitted together with this Notice of Withdrawal of Tender.

---

| | | |
|:---|:---|:---|
| Signature | Print Name of Authorized Signatory (and Title if applicable) | Date  |
| Signature | Print Name of Authorized Signatory (and Title if applicable) | Date |

---

Notice of Withdrawal of Tender – BlackRock Private Credit Fund

(PAGE 2 of 2)

## Ex-Filing

?xml version='1.0' encoding='ASCII'?

------

**Exhibit 107**

**Calculation of Filing Fee Table**

**SC TO-I**

(Form Type)

**BlackRock Private Credit Fund**

(Exact Name of Registrant as Specified in its Charter)

**<u>Table 1: **Transaction Value**</u>**

---

| | | | |
|:---|:---|:---|:---|
|  | **Transaction Value** | **Fee Rate** | **Amount of Filing Fee** |
| &nbsp;&nbsp; Fees to Be Paid  | $82847647.68<sup>(1)</sup> | 0.00013810 | $11441.26<sup>(2)</sup> |
| &nbsp;&nbsp; Fees Previously Paid  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; **Total Transaction Value** | $82847647.68<sup>(1)</sup> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; **Total Fees Due for Filing**  |  |  | $11441.26<sup>(2)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp; **Total Fees Previously Paid**  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; **Total Fee Offsets**  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; **Net Fee Due**  |  |  | $11441.26<sup>(2)</sup> |

---

(1) Calculated
as the aggregate maximum purchase price based upon the net asset value per
share as of March 31, 2026 of $23.52 and the offer to purchase up to 3,522,434 shares.

(2) Calculated
at $138.10 per $1,000,000 of the Transaction Value in accordance with Rule 0-11
under the Securities Exchange Act of 1934, as amended, as modified by Section 6(b)
Filing Fee Rate Advisory for Fiscal Year 2026.

------